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Abstract
Epidemiological data suggest that viral infections might be predisposing factors for
bacterial meningitis or carriage of type b Haemophilus influenzae (Hib), Neisseria
meningitidis or Streptococcus pneumoniae, the three pathogens most commonly
associated with bacterial meningitis. Non-secretors of ABO blood group antigens are
over-represented among patients with bacterial meningitis and in populations affected
by some outbreaks. The first objective of the study was to examine the hypothesis
that non-secretors were also over-represented among patients with respiratory viral
infections. Compared with the local population, there was a significantly higher
proportion of secretors among patients with disease due to respiratory syncytial virus
(RSV), influenza A vims, rhinovirus and ECHO vims. The hypothesis that Leb
and/or H-type 1 antigens present on cells or in body fluids of secretors might be
receptor(s) for RSV was examined. Affinity purified molecules with Leb or H type 1
determinants or synthetic receptor analogues did not decrease the infectivity of RSV
for HEp-2 cells (a human epithelial cell line).
Bacterial attachment to mucosal surface is an important prerequisite for infection.
The second major objective was to assess the effect of RSV-infection of HEp-2 cells
on binding of bacteria responsible for meningitis. Binding of bacteria labelled with
fluorescein isothiocyanate (FITC) to HEp-2 cells and RSV-infected ELEp-2 cells was
compared by flow cytometry. Strains of meningococci (3) and Hib (5) expressing
antigens of different serogroups, serotypes and subtypes and a strain of Staphylococcus
aureus bound significantly more effectively to virus infected cells compared with
uninfected cells. Similar patterns of increased binding of unlabelled meningococci to
monolayers of RSV-infected cells were also observed.
Studies to identify the changes on the cell surface associated with RSV-infection
responsible for enhanced binding were carried out with one strain of meningococcus.
Viral infection of HEp-2 cells did not enhance the expression of Lewisa antigen, a
proposed receptor for bacteria in non-secretors. Monoclonal antibodies to the
-II-
attachment glycoprotein G of RSV decreased the bacterial binding to infected HEp-2
cells; but monoclonal antibodies to the fusion glycoproteins F did not affect the
binding. Bacteria bound to infected cells also decreased the binding of monoclonal
anti-G but not anti-F. Virus particles attached to bacteria. Monoclonal anti-G
interfered with the viral attachment to bacteria but anti-F did not. These observations
indicate that the G glycoprotein might act as a bacterial receptor.
G glycoprotein is a heavily O-glycosylated molecule. Deletion of O-linked sugars or
removal of sialic acid from the surface antigens of uninfected or RSV-infected cells
resulted in increased binding of bacteria. These data suggest that the protein moieties
of the G glycoprotein and other molecule(s) native to HEP-2 cells might be the
receptors for bacteria.
The present findings indicate that infection with RSV might be one of the factors
contributing to increased colonization by the bacteria responsible for meningitis.
Identification of the components on the infected HEp-2 cells involved in bacterial
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Chapter 1
General Introduction
Acute bacterial meningitis is a medical emergency that involves the leptomeninges
and the subarachnoid space in a process of acute pyogenic inflammation. Early
recognition of the condition, rapid detection of the etiologic agents, initiation of
appropriate antimicrobial therapy and treatment of associated abnormalities and
conditions are important for successful management. As the incidence of fatalities
and complications is very high, identification of predisposing factors and the use of
chemoprophylaxis and vaccination of those at risk are important.
1.1. Major pathogens
Haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumoniae are
the most common bacterial species causing meningitis. Greater than 90% of the
endemic disease in children in the Sudan during 1985-1986 was caused by one of
these three bacteria [Salih, 1990]. The death rate for the disease is high. That for
meningitis due to H. influenzae varies from less than 5% in the USA to above 30% in
Papua New Guinea [reviewed by Munson et al., 1989], Post-infection neurological
and intellectual complications occur in 36% of patients with meningitis due to
H. influenzae [Feigin, et al., 1976]. The death rate is 10-20% in patients with disease
due to N. meningitidis in industrialized countries and greater in developing countries
[reviewed by Peltola, 1983]. The death rate approaches 80% in patients older than 50
years suffering from meningitis due to Strep, pneumoniae [Mufson et al., 1982],
I.1.1. H. influenzae
H. influenzae is a small (0.1 X 0.3 um), non-motile, non-spore-forming,
Gram-negative coccobacillus. Its virulence is related to production of a
polysaccharide capsule. The bacteria can be classified into 6 types, designated a-f,
based on antigenic differences in the capsules. Type b H. influenzae (Hib) accounts
for more than 95% of the invasive disease in children [reviewed by Moxon, 1990].
1.1.2. N. meningitidis
N. meningitidis (meningococcus) is a Gram-negative capsulate diplococcus with an
average size of 0.6 X 0.8 um and flattened shape. The bacteria can be classified by
seroagglutination based on the immunological specificities of the capsular
polysaccharides into 13 serogroups: A, B, C, D, X, Y, Z, E, W135, H, I, K and L
[reviewed by Appicella, 1990]. Nine of these serogroups are known to cause disease
in humans, and most disease is caused by serogroups A, B or C [reviewed by
Schwartz et al., 1989]. The bacteria are also classified into serotypes on the basis of
outer membrane proteins and 11 immunotypes of lipooligosaccharides present in the
bacterial cell envelope [Zollinger and Mandrell, 1977]. Significant numbers of
isolates are, however, non-typable. The endemic form of the disease appears to be
caused by a heterogeneous collection of serotypes whilst a single serotype is usually
involved in epidemics [Appicella, 1990],
1.1.3. Strep. pneumoniae
Strep, pneumoniae (pneumococcus) is a Gram-positive capsulate bacterium. Of the
84 recognized capsular types, 1, 3, 4, 7, 8, 9, 12 and 14 are most often associated with
bacteraemia, including cases ofmeningitis [reviewed by Mufson, 1990].
1.2. Epidemiology
Hib affects mainly infants and children under the age of 6, mostly between 0-2 years;
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and it is responsible for over 60% of cases of pyogenic meningitis in industrialized
and developing countries [Greenwood, 1984; Schwartz et al., 1989; Takala et al.,
1989; Nazareth et al., 1992], Endemic meningococcal meningitis is found mainly in
children between 6 months and 5 years. The epidemic form of the disease is
prevalent in a relatively older age group: children over the age of 10 and young adults
[Geiseler et al., 1980; Peltola, 1983; Jones and Kaczmarski, 1991]. Carrier-to-case
ratio is higher in the endemic than the epidemic form of meningococcal disease
[Greenwood, 1984]. Meningococcal disease also affects recruits in military
institutions [Varela and Gilmore, 1971; Makela et al., 1975; Griffiss and Bertram,
1977]. Strep, pneumoniae is most frequently associated with the disease in adults
and is isolated from only 10% of children with meningitis [Greenwood, 1984], All
three pathogens cause the endemic form of the disease. Meningococci groups A and
C, and less frequently group B, are associated with epidemics [Greenwood, 1984].
Most cases of meningococcal meningitis reported in the USA and Belgium occur in
winter and early spring [reviewed by Peltola, 1983]. Peak incidence of the disease in
England and Wales is in January [Jones and Kaczmarski, 1991]. Peak incidence of
invasive disease, including meningitis, due to Hib is from October to January in
England and Wales [Nazareth et al., 1992].
The carriage rates vary with age, socioeconomic conditions and with the presence of
ongoing epidemics. Meningococci are carried by 5-30% of individuals in
non-epidemic periods, whilst the bacteria can be isolated from up to 100% of the
population during epidemics [reviewed by Devoe, 1982], Meningococcal carriage
rate was determined in two groups of family contacts of meningitis patients. The first
group was comprised of contacts from 21 families in which there was a case of
meningococcal meningitis. Individuals in the second group were from 24 families in
which there was a case of meningitis due to H. influenzae or Strep, pneumoniae. In
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each group, 64 individuals were cultured within 48 hours of the diagnosis of the index
case. Meningococcal carriage rate was 39% in the first group of family members
compared to 1.6% in the second group [Olcen et al., 1981].
Specimens from 41 households with one or more children, representing a
cross-section of the social strata and in which there was no meningococcal disease
were cultured bimonthly over a period of 32 months. Among 238 individuals tested,
18% were carriers of meningococci. Serogroup B was obtained from 50% of the
positive cultures [Greenfield et al., 1971]. Group specific carriage rates are, however,
of little value in determining the population dynamics of meningococcal infection. In
contrast, serotype specific carrier rate is a reliable indicator for the disease in a
community [Griffiss etal., 1977], In another study the carriage rate among
close contacts of patients was significantly higher than in the control population.
Meningococci were isolated from 17% of 315 household contacts compared with
only 2% in a comparable population of non-contacts [Cartwright et al., 1991b].
Carriage rates have been estimated to be 3-5% for Hib and 50-80% for non-typable
strains of H. influenzae [Moxon, 1986]. Turk [1984] has emphasized that the low
carriage rate of Hib in children is due to a brief period of colonization (2 months) in
children under 5; but, Hib was isolated from a much higher proportion of children
(38.5%) when throat swabs from these children were cultured on multiple occasions
during the first 5 years of life. The likelihood of occurence of secondary cases of
meningitis due to Hib in the households within 30 days of occurence of the index case
was 585 times higher than in the general population [Ward et al., 1979]. OMP typing
has confirmed that the secondary cases are caused by the same strain responsible for
the respective index case [Kaplan et al., 1983].
Pneumococci have been isolated from 5 to 70% of normal adults [reviewed by
Mufson, 1990], In a study over a period of 80 weeks, among 52 normal families (265
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persons) residing in a low income housing project, 39% members acquired
pneumococci in their throat; 85% of these subjects were under the age of 20 years
[Suhs and Feldman, 1965]. Pneumococci and meningococci usually require several
weeks to spread in a family following the initial nasopharyngeal acquisition by one of
the family members [Suhs and Feldman, 1965; Greenfield et al., 1971].
1.3. Pathogenesis of bacterial meningitis
1.3.1. Colonization
Colonization of the human nasopharynx might result in the bacteria remaining as part
of the commensal flora on the mucosal surface, or they might spread to adjacent
anatomical sites such as the middle ear or result in systemic infection [Beachey,
1981; DeVoe, 1982; Kaplan et al., 1983]. Fresh isolates of N. meningitidis from the
nasopharynx of carriers and patients are invariably pilate [reviewed by Heckels,
1989]. Pilate strains attach more effectively to human epithelial cells than isogenic
bacteria from which pili are removed or non-pilate laboratory strains [Stephens and
McGee, 1981],
There are conflicting reports on the importance of pili for attachment of H. influenzae
to cells. All the clinical isolates of non-typable H. influenzae were found to be pilate,
although the percentage of pilate bacteria in each isolate varied from 10-100%
[Bakaletz et al., 1988b]. In comparison, only 16% of the samples obtained from
children with systemic Hib disease were found to be pilate [Mason et al., 1985].
These data suggest that either pili are not necessary for nasopharyngeal colonization
in children or loss of pili is associated with invasion of the host.
Pili of H. influenzae are not essential for binding of the bacteria to cells of different
origins. Non-pilate bacteria attached more efficiently to HEp-2 cells than pilate
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strains [Sable et al., 1985]. In contrast, human buccal epithelial cells bound pilate
strains more effectively [Pichichero et al., 1982]. In addition to pili, ligands
responsible for attachment to human nasopharyngeal cells have been demonstrated on
the surface of Hib [Farley et al., 1990].
1.3.2. Mucosal invasion by bacteria
Stephens et al. [1983] studied mucosal invasion by the bacteria using nasopharyngeal
tissue obtained from healthy patients undergoing surgery to remove adenoid tissue.
The resected tissue maintained in tissue culture medium was exposed to pilate strains
of N. meningitidis. The bacteria attached selectively to microvilli of non-ciliated
columnar epithelial cells; but at the same time, they were found to decrease the
activity of ciliated cells. The microvilli of the cells binding the bacteria became
distorted, long, thin and irregular in distribution. Such changes were not observed on
the neighbouring cells to which meningococci did not attach. The microvilli
restructured themselves around the bacteria. Bacteria were endocytosed within
6-12 hours of inoculation. The strains used in these assays were pilate, but no
comment was made about change in pili during the attachment and entry process. In
another study, pili were involved only in the initial stages of binding whilst
irreversible binding was thought to result from covalent linkage between the two
surfaces [Rogers, 1979].
In other experiments [Read et al., 1991], inferior turbinates from patients with a
history of nonallergic nasal obstruction were resected and maintained in nutrient
medium. The cultures were incubated with non-typable strains of H. influenzae for
24 hours. Ciliary depletion was observed on the ciliated cells while both ciliated and
non-ciliated cells showed cytopathic effects such as cytoplasmic blebs and
mitochondrial abnormalities. The bacteria were characteristically associated with
damaged ciliated and non-ciliated mucosal cells. Similar associations with damaged
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epithelial cells were also observed for 5 other clinical isolates of the bacteria. It was
suggested that, in the individuals with impaired mucociliary clearance, the products
from the entrapped bacteria are detrimental to host tissues and damage the mucosa,
paving the way for bacterial attachment.
A study comparing the initial stages in the pathogenesis of N. meningitidis and
H. influenzae infections was conducted by Stephens and Farley [1991] using
nasopharyngeal tissues of adenoids resected from children. Compared with
meningococci, H. influenzae attached in larger numbers to the mucus lining the
epithelium. Infection with H. influenzae led to breakdown of tight intercellular
junctions so that the organisms were found in the intercellular spaces. Meningococci,
in contrast, were endocytosed by non-ciliated cells. Both the pathogens produced
factors that were ciliostatic and cytotoxic for ciliated cells.
Bacteraemia occurs in many forms of bacterial disease. Concomitant with the
bacteraemia, or at various times thereafter, the bacteria spread to different organs and
systems in the body. How these bacteria cross the blood-brain barrier is not known.
A role for surface polysaccharides in predilection of these bacteria for the meninges
has been suggested [McCracken, 1976].
I.3.3. The role of bacterial components in pathogenesis
1.3.3.1. The Capsule
The role of the bacterial capsule in pathogenesis of bacterial disease was recognized
as early as 1920s by Dr. O.T. Avery (Rockfeller Institute, USA) who described the
significance of the capsule in pneumococcal disease. The presence of a capsule
appears to be important in the pathogenesis of meningococcal infection as
non-capsulate strains are usually non-pathogenic [Salit and Morton, 1981].
7
Non-capsulate strains of H. influenzae account for the majority of localized disease,
e.g., otitis media. Capsulate bacteria, in contrast, are responsible for systemic
disease, e.g., meningitis [reviewed by St. Geme and Falkow, 1990].
Studies performed on infant rats inoculated intranasally with Hib indicate that the
bacteria can be isolated from the blood stream within minutes of inoculation.
Concomitant isolation of Hib from regional and distant lymph nodes in rats with
sterile blood cultures 24 hours after intranasal inoculation with the bacteria indicates
a direct invasion of nasopharyngeal blood vessels as an initial determinant of
systemic infection [Rubin and Moxon, 1983]. The presence of a characteristic
capsule is important for the bacteria to survive and replicate in the blood stream. In a
rat model, genetically related transformants which expressed different capsular
polysaccharides survived significantly less efficiently in the blood compared with
capsulate strains of Hib [Zwahlen etal., 1983].
Specific antibody levels might also be important in the pathogenesis of disease
caused by Hib. Robbins et al. [1973] measured anti-capsular antibodies in 30 patients
with epiglottitis, 30 patients with meningitis and 44 controls. The meningitis patients
had markedly lower levels of anti-capsular antibodies compared with epiglottitis
patients and controls. Similar trends in the antibody level in the patients with
epiglottitis and meningitis due to Hib were found by Kayhty et al. [1981].
Masson et al. [1982] examined the effect of the group B meningococcal capsule on
bacterial virulence for mice by comparing a wild type strain and a spontaneous
isogenic mutant deficient in polysaccharide production. The loss of polysaccharides
was found to be associated with dramatic loss of virulence.
1.3.3.2. Lipopolysaccharide/Lipooligosaccharide
The deleterious effect of endotoxins released by the bacteria on the host system can
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be due to direct action on the tissues [reviewed by Jacobs and Tabor, 1990],
disturbance caused in the central nervous system or release of cytokines such as
tumour necrosis factor (TNF). Ducker and Simmons [1968] found that endotoxins
introduced into the ventricles of the brain of dogs produced a massive oedema of
lungs and haemorrhages in the subendocardium, viscera and adrenal glands. These
changes were not associated with abnormalities, such as hypoglycemia, alterations in
serum enzyme levels and plasma volume characteristic of endotoxic shock or with
abnormalities caused by increased intracranial pressure. The quantities of the
endotoxins administered intracranially were not sufficient to produce symptoms when
administered intravenously. Systemically, bacterial endotoxins elicit the production
of host factors such as TNF and cachectin that might in turn lead to shock and death
[Beutler and Cerami, 1987]. Waage et al. [1987] measured the level of TNF in
patients with meningococcal meningitis. The level was high in 10 of 11 patients who
died compared with 8 of 68 survivors from the disease.
1.3.3.3. Pili
Pili are not associated with virulence of Neisseria gonorrhoeae in guinea pigs.
Virulence of the bacteria was determined by their survival after the bacteria contained
in polypropylene chambers were implanted in flanks of the animals. Loss of pili due
to glucose-limited growth did not result in loss of virulence. In contrast,
cystine-limited gonococci were pilate but avirulent [Keevil et al., 1986], Pili were,
however, demonstrated on the bacteria isolated from CSF from a patient with
meningococcal meningitis indicating a possible role for pili in the later stages of
disease [Stephens et al., 1982]. In contrast, pili were not demonstrated on the isolates
of Hib from blood or CSF of infected rats [Kaplan et al., 1983].
1.4. Factors affecting host susceptibility to bacterial meningitis
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1.4.1. Maturation of infant immune system and correlation with the peak of disease
Meningococcal disease mainly affects children in the age range of 6 months to 5
years. Infants under 6 months are relatively protected by bactericidal antibodies
acquired from the mother before birth. Infants born to mothers who are deficient in
protective antibody or whose isotype-response is limited to IgM are not protected
from the disease during this period. Appearance of specific antibodies against
meningococci in children of 5 years and older is correlated with low incidence of
disease. The adult levels of antibodies are reached by about 10 years of age
[Goldschneider et al., 1969]. Progressive reduction in the incidence of the disease
after 2 years of age correlates with the rise of serum bactericidal antibodies against
serotype antigens of the bacteria [Frasch, 1977]. Antibodies to polyribotol phosphate
(PRP), the capsular polysccharide of Hib, are bactericidal. Minimal levels of
anti-PRP antibodies are found in infants between 3 to 6 months of age [Moxon, 1990]
which corresponds with high incidence ofmeningitis due to Hib in this age group.
1.4.2. Protective antibody response
Antibodies against the PRP capsular antigen of H. influenzae activate complement by
both the classical and the alternative pathway and are opsonic [Steele et al., 1984].
Robbins et al. [1973] found PRP to be present in a variety of Gram-positive bacteria.
Bactericidal activity against H. influenzae was reduced by half by prior interaction of
sera with bacteria containing PRP. Many human commensal E. coli strains also
express epitopes that cross-react with H. influenzae. Anderson et al. [1972]
demonstrated antigenicity of bacterial components of Hib other than PRP in 60% of
114 individuals examined. The sera from these subjects lacked detectable serum
anti-PRP activity but still possessed bactericidal activity against Hib. Hib differed in
their susceptibility to anti-somatic antibodies but were uniformly sensitive to
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anti-capsular antibodies. Bactericidal activity of antibodies to non-capsular bacterial
components was also demonstrated by Steele et al [1984].
Presence of G2m(n) allotype, a genetic marker of IgG2 antibodies, has been
associated with high levels of the IgG2 isotype to PRP. The finding that the
antibodies produced against bacterial antigens other than PRP can be bactericidal to
Hib is further supported by the reports that individuals who are of G2m(n) n-/n- (not
able to produce IgG2 isotype) are not more susceptible to these infections than
G2m(n)-positive individuals [Takala etal., 1991].
The antibody response during infection depends upon the maturity of the immune
system. Kayhty et al. [1981] found that 61% of 77 patients >17 months of age had a
>4 fold rise in the antibody level; in contrast, only 10% of 48 patients in the younger
age group showed a similar rise.
Antibodies of all isotypes are produced against N. meningitidis, but they are not
necessarily protective. Griffiss [1975] and Griffiss and Bertram [1977] demonstrated
that the acute phase sera from 24 of 28 cases of meningococcal disease were inactive
against the strains prevalent in the USA at that time; but, these became lytic when
IgA was removed by immunoadsorption. Presence or absence of IgG in the sera was
largely insignificant while IgM was bactericidal. The blocking effect of the IgA for
serogroups B, Y and C was also observed at 12, 27 and 33 days after the first
isolation of the bacteria.
Edwards et al. [1977] measured complement fixing antibodies against meningococci.
They found an overall lag of 9 days between the acquisition of the bacteria and the
appearance of significant amounts of antibodies. Peak titres were detected in the
third week after the first positive culture of the bacteria.
The antibody response to group B polysaccharide is not as effective as to antigens of
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the other serogroups. With monoclonal antibodies specific for the group B
meningococcal capsule, it has been shown that cross-reactivity exists between the
bacterial capsule and central nervous system (CNS), cardiac, hepatic and renal
glycoproteins of the infant rat. As the animal matures, the cross-reactivity persists
only in the CNS [Finne et al., 1987]. Identification of a-(2-8) linked oligomers of
sialic acid in polysaccharides of group B meningococci and in gangliosides of human
brain tissue also suggested cross-reactivity [reviewed by Jennings et al., 1985]. Poor
immunogenicity of group B polysaccharide seems to be due to cross-reactivity with
host tissues.
1.4.3. Role of complement
Complement factors are involved in the elimination of bacteria through their
bactericidal activity and complement-mediated phagocytosis. Some complement
deficiencies (C 5-9) are found to be associated with meningococcal disease [Fijen et
al., 1989].
In a rat model, the presence of complement factors is important in clearance of
capsulate and non-capsulate strains of H. influenzae from the blood [Zwahlen et al.,
1983]. Bactericidal activity can be demonstrated in human sera in which complement
factor C2 (classical pathway) or factor D and properdin (alternative pathway) were
selectively inactivated [Steele et al., 1984], The evidence that Hib can activate the
alternative pathway is also demonstrated by consumption of C3 in the absence of C4
in guinea pig serum incubated with the bacteria. PRP is not responsible for the
activation since non-capsulate organisms can also activate this pathway [Quinn et al.,
1977]. It has, however, been suggested that the major contribution of complement in
protection against Hib relates to its opsonic rather than its bactericidal activity
[Moxon and Winkelstein, 1988].
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1.4.4. Role of properdin
Properdin, a serum protein important in the alternative pathway of complement
activation, contributes to protection against meningococcal infection. Densen et al.
[1987] reviewed the literature reporting the occurrence of bacterial meningitis in
individuals deficient in properdin. Meningococcal meningitis affected 8 of the 16
individuals with the deficiency and there was a high fatality rate in this group. In
another study, 46 patients of 10 years or more with meningococcal disease due to rare
serogroups X, Y, Z, W135 or 29E were investigated. Properdin deficiency was found
in 9, C3 deficiency in 5 and deficiency of terminal components of complement in 9
[Fijen et al., 1989]. This suggests that the alternative pathway is important in
protection against the rare serogroups of meningococci. The hypothesis that
complement provides the only bactericidal mechanism in the serum against these
serogroups is unlikely since the rare serogroups are efficiently immunogenic [Griffiss
et al., 1981].
1.4.5. Nutritional status
The role of nutritional factors in susceptibility to meningitis has not been evaluated.
These factors have, however, been examined for other infectious diseases. An
association is found between chronic alcoholism and pneumonia caused by
H. influenzae. In a retrospective survey of cases of pneumonia recorded between
1942 and 1971, 30% of the adults were alcoholics. A similar survey of the cases
reported between 1970 to 1974 indicated alcoholism in 50 % of the adult patients
[Levin etal., 1977].
Klebsiella pneumoniae bind in larger numbers to nasopharyngeal epithelial cells
obtained from children with mild to severe vitamin A deficiency than to the cells
from a control population [Chandra, 1988]. The bacteria also attach more effectively
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to the tracheal and buccal epithelial cells obtained from children suffering from
protein-energy malnutrition compared with the control [Chandra and Gupta, 1990].
These studies were not controlled for presence of viral infections.
1.4.6. Trauma
Bacteraemia due to H. influenzae does not always lead to localized disease [Marshall
et al., 1979]. Trauma can convert unnoticed bacteraemia into an overt disease. Turk
[1984] has reported the occurrence of Hib disease localized to traumatized parts of
the body including meningitis in patients with recent history of head injury without
fracture.
1.4.7. Socio-environmental conditions
In a case-control study of 108 patients with meningococcal disease and 103 controls,
factors such as bacterial carriage and acute respiratory infections were significantly
associated with disease. Crowding was not directly associated with the disease,
although it influenced the incidence of the disease by increasing the carriage rate and
the incidence of acute respiratory infections [Moore et al., 1990]. In contrast,
crowding was not associated with the carriage rate in a study conducted by Stuart et
al. [1988]. They found associations, which were not statistically significant, between
low socio-economic conditions and the disease in 83 cases of the disease compared
with 88 controls. The houses of the patients were generally more damp and less
heated than the average.
Carriage is associated with active smoking: In a study carried out by Blackwell et al.
'
[1990], 46% of 37 smokers were carriers compared with 25% carriers in 349
non-smokers. Passive exposure to cigarette smoke did not predispose to carriage. In
contrast, passive smoking was a risk factor for disease in adults over 20 years (n=10)
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and in children under 12 years (n=40) compared with similar numbers of controls.
[Stuart et al., 1988]. Smoking, both active and passive, was associated with carriage
of meningococci in a study of Greek military recruits; and there was a strong
correlation between carriage and number of cigarettes smoked per day [Blackwell et
al., 1992]. A similar pattern of association was observed between carriage and
smoking in 87 pairs of carriers and non-carriers of 12 years or older [Stuart et al.,
1989]. The risk of carriage in active smokers was proportional to the number of
cigarettes per day. No other factor such as nasal symptoms, tonsillectomy or
adenoidectomy was associated with carriage in this study. Tonsillectomy, however,
was found to be associated with carriage in another study [Kristainsen and Elverland,
1984]. Fifteen of the 62 individuals after tonsillectomy compared with none of 62
controls converted from non-carrier to carrier state. The authors did not, however,
comment on the higher incidence of carriage in the subjects before tonsillectomy
compared with the controls.
Gonococcal infection in military recruits is suggested to contribute to susceptibility to
meningococcal disease. Lipooligosaccharides of the two species are antigenically
cross-reactive. The amount of bactericidal activity against meningococci of
serogroups A, B and C is negligible among patients with gonorrhoea. This suggests
that gonococci might be adsorbing serum antibodies bactericidal to meningococci and
thus enhancing the susceptibility to infection by the latter [Winstanley et al., 1983].
1.4.8. Secretor status and susceptibility to infectious disease
1.4.8.1. Genetics and expression of ABH and Lewis blood group antigens
The ability to secrete the water-soluble form of the ABH blood group antigens in
body fluids is determined by the secretor (S) gene located on chromosome 19
[Watkins, 1980]. The secretor gene is in the same linkage group as the Lewis gene
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and both code for fucosyl transferases that modify the type 1 precursor chain. The
expression of H and Lewis antigens on cells and in body fluids of secretors and
non-secretors is summarized in Table 1.1. Non-secretors express only Lewis3 while
secretors express Lewisb and variable amounts of Lewis3.
A, B, H and Lewis blood group substances are found in two forms, glycolipid mainly
present in the cell membrane and glycoprotein mainly present in the secretions. The
glycoproteins are macro-molecules composed of 10-20% amino acids and the
remainder is carbohydrates. The carbohydrate moieties consist of a basic precursor
chain to which different monosaccharides are added by cellular enzymes. Of the 4
types of precursor chains (Table 1.2), type 1 and type 2 appear to be the most
common . Type 1 chains are the main carriers of blood group determinants in
secretions and on the lining and glandular epithelia. In comparison, blood group
antigens on theerythrocytes are mainly type 2 precursor chains [Tilley et al., 1975;
Oriol et al., 1986]. The interactions of the Se gene- and Le gene-coded enzymes on
the type 1 precursor chain are illustrated in Fig 1.1.
Secretor status is usually determined by a haemagglutination inhibition assay with
saliva [Mollison, 1979]. Determination of Lewis blood group by agglutination of red
cells or detection of these antigens in saliva has also been used to determine secretor
status [reviewed by Mourant et al., 1976].
1.4.8.2. Secretor status and infectious diseases
Non-secretors are significantly over-represented among patients with a variety of
bacterial diseases and superficial yeast infections. Non-secretion is also associated
with some autoimmune diseases for which infectious triggers have been proposed
(Table 1.3).
Non-secretion of blood group antigens is associated with invasive disease due to
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Table 1.1. Distribution of H and Lewis antigens in the




Secretions cells Secretions cells
Lea + + + +
JO0) - - + +
H-type 1 - - + +
H-type 2 - + - +
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Figure 1.1. Modification of type 1 precursor chain by
fucosyltransferases coded by the Lewis and the secretor genes.
19









Glynn et al., 1959
Neisseria meningitidis Blackwell et al., 1986a
Strept. pneumoniae ti
Haemophilus influenzae Blackwell et al., 1986b
Gastrointestinal tract
Vibrio cholerae Chaudhuri and Das-
Adhikary, 1978
Peptic ulcers reviewed by Mourant
et al., 1978
Urinary tract
E. Coli Kinane et al., 1982
Blackwell et al., 1987b
Oral cavity
Candida albicans Thorn et al., 1989
Dental caries Holbrook and Blackwell,
1989
Autoimmune diseases
Ankylosing spondylitis Shinebaum et al., 1987
Insulin dependent
diabetes mellitus
Blackwell et al., 1987a
Graves' disease Collier et al., 1988
20
meningococci, Hib and pneumococci, the 3 major bacterial pathogens causing
meningitis. The secretor gene is inherited in a mendelian-dominated pattern, and
75-80% of European populations are secretors while 20-25% express the recessive
non-secretor phenotype. Regional variations in these phenotypes are also reported
[Lincoln and Dodd, 1972; Mourant et al., 1976]. In areas where there have been
prolonged outbreaks of meningococcal disease, Iceland, Stonehouse, Gloucestershire
and Plymouth in the UK, there are significantly higher proportions of non-secretors in
the population [Blackwell et al., 1986(a); Eriksson et al., 1986; Blackwell et al.,
1989(c); Blackwell and Weir, 1990],
Several hypotheses have been suggested to explain the increased susceptibility of
non-secretors to bacterial diseases. 1) Lewis® antigen present in higher amounts in
non-secretors might be a receptor for microorganisms. There is some evidence that
Lewis® antigen might be a receptor for Candida albicans [May et al., 1989; Tosh and
Douglas, 1991; Aly, 1992]. Buccal epithelial cells (BEC) obtained from
non-secretors bound staphylococci more effectively compared with BEC from
secretors [Saadi et al., submitted for publication], 2) Non-secretors might be more
susceptible to bacterial diseases because of lower level of serum and salivary
antibodies. Recent studies have not confirmed early reports which suggested lower
levels of serum or secretory IgA in non-secretors [Blackwell, 1989]. Non-secretors
do, however, have significantly lower levels of salivary IgM [Zorgani et al. in press].
3) The secretor gene and the gene for the third component of complement (C3) are in
the same linkage group. C3 levels were found slightly lower in non-secretors
compared with secretors; and 7 of 8 subjects whose C3 levels were below the lower
limits of the normal range were non-secretors [Blackwell et al., 1988].
1.4.9. Viral infections predisposing to bacterial diseases
Virus infections are associated with enhanced colonization and disease caused by a
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variety of bacterial pathogens. Most studies have investigated the association between
influenza virus and bacteria causing pneumonia, probably because of the high
incidence of lung complications among the populations experiencing epidemics in
New York during 1957-1958 [Louria et al., 1959], in Connecticut during 1957
[Petersdorf et al. 1959] and in Hong Kong during 1969 [Schwarzmann et al., 1971].
Increased adherence of staphylococci to the pharyngeal cells of volunteers infected
with attenuated influenza virus was observed by Musher and Fainstein [1981]. This
finding was repeated using MDCK cells (a canine kidney cell line) infected with the
virus [Sanford et al., 1986]. Strep, pneumoniae bound more readily to the tracheal
epithelial cells of influenza virus infected mice compared with the controls
[Plotkowski et al., 1986].
Gram-negative bacilli are not normally present in the oropharyngeal flora. A survey
was undertaken over a period of 11 months involving 89 staff house officers to assess
the effect of clinical viral respiratory tract infections on the isolation of
Gram-negative bacilli and staphylococci. The results showed that colonization by the
bacteria increases significantly during episodes of viral illness compared with illness
free periods [Ramirez-Ronda et al., 1981].
1.4.9.1. Evidence for virus infections as predisposing factors to infection by bacteria
causing meningitis
1.4.9.1.1. N. meningitidis
The elderly are not generally susceptible to meningococcal disease. In contrast, an
outbreak of meningococcal meningitis in a geriatric ward affected 11 of 55 women,
27 of whom were suffering from A2 influenza virus infections. Significant
association between the two pathogens was also shown by the serological evidence in
these patients [Young et al., 1972], Data from a military training center covering a
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period from 1967 to 1971 indicated a lag of 7-10 days between acute respiratory
diseases necessitating hospitalization and meningococcal disease [Edwards et al.,
1977]. It is not clear from the study which pathogens were involved in the acute
respiratory diseases. Upper respiratory tract infecnons with adenovirus,
parainfluenza, respiratory syncytial virus (RSV) and rhinovirus or mycoplasma have
been reported to be risk factors for epidemic disease due to group A Neisseria
meningitidis [Moore et al., 1990].
In a survey of patients with meningococcal disease. 46% of 69 cases had prodromal
symptoms affecting the upper respiratory tract within 1 week before onset of signs
and symptoms of the disease [Olcen et al., 1979]. An investigation of household
contacts of patients with meningococcal disease showed a bacterial carriage rate of
61% among the individuals with upper respirators symptoms compared with only
14% among those with no symptoms [Olcen etal., 1981].
Infections by adenovirus and influenza B virus were detected by isolation of the
viruses or by serological methods in a study involving 160 cases of meningitis due to
H influenzae and N. meningitidis and 138 controls. The viruses were significantly
associated with the bacterial disease [Krasinski e: al., 1987], The control group
selected in this study was not ideal since they were rot age-matched with the patients
and were admitted to hospital for elective surgery, supposedly free of respiratory tract
infections. The finding of an association of adenovirus infection with meningococcal
disease has been confirmed [Moore et al., 1990]. In a previous study, however,
adenovirus infections or vaccination with the attenuated strain did not change the
pattern of dissemination or invasiveness of meningococci in military recruits
[Artenstein etal., 1967],
A recent report [Cartwright et al., 1991a] indicates that 38% of 53 meningitis patients
of 10 or more years of age compared with 6% of individuals in a control group had
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high titres of antibodies against influenza A virus. Possible associations with other
respiratory tract viruses were not reported in this study. Analysis of the data in this
study obtained from the questionaires supplied to the patients and the control group
showed that a high proportion of meningitis patients suffered from a flu-like
syndrome during the previous 2 months.
1.4.9.1.2. H. influenzae
Respiratory syncytial virus (RSV) infection of children has been significantly
associated with bacterial superinfection. Bacteria were cultured from 47 of 194 RSV
infected children. H. influenzae was the most common bacterium, isolated from 50%
of the 47 children. [Meguro et al., 1988]. H. influenzae and Strep, pneumoniae were
isolated from 32% of 66 children suffering from RSV infections [Wahlgren et al.,
1984]. The bacteria were not typed in this study but the samples were obtained from
blood or lungs indicating systemic infection caused by invasive strains. The data in
both of these studieswerenot compared with any control group since the studies were
primarily conducted for comparison of antibiotic treatments and X-ray findings. The
finding is, however, significant when compared with the low carriage rate of 3-5% of
Hib in a similar age group [Moxon, 1986].
A 14-year prospective study of 110 children indicated that attacks of RSV and
adenovirus infections were significantly associated with colonization and disease
(e.g., otitis media) caused by H. influenzae and Strep, pneumoniae [Henderson et al.,
1982]. Examination of sera from 51 children with viral respiratory tract infections for
the concomitant presence of the bacterial antigens or specific antibodies to H.
influenzae and pneumococci indicated a higher incidence of mixed viral and bacterial
infections compared with earlier reports [Hietala et al., 1989].
Children hospitalized during an epidemic of RSV infection and during the
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post-epidemic period were screened for the presence of RSV and evidence of
coinfection by bacteria. The incidence of infection by H. influenzae and Strep,
pneumoniae based on a significant rise of the antibody titre or detection of
pneumococcal antigens in serum or urine was significantly higher in 90 RSV-positve
children during epidemic than 91 RSV-negative children admitted with similar
complaints during the epidemic or with 99 children after the outbreak [Korppi et al.,
1989]. The proportion of RSV-positive cases and the incidence of co-infection by
bacteria in the post-epidemic group is not provided in the data. Associations with
other bacteria such as meningococci were not examined in the study. These data
suggest that infection with a variety of respiratory tract viruses enhances
susceptibility to bacterial diseases.
1.4.9.1.3. Strep, pneumoniae
Children (69) suffering from respiratory illness were compared with a control group
of 28 age-matched surgical patients who were free of infections. Both viruses
(mostly parainfluenza 3 and RSV) and bacteria (pneumococci and streptococci) were
detected in 17% of patients compared with 4% in controls [Nickol and Cherry, 1967].
The bacteria were detected by throat swab cultures and the viruses were detected
either by positive culture or by serological evidence. Simultaneous spread of
rhinovirus and pneumococci occurred more commonly in families [Gwaltney et al.,
1975] and in apparently well, pre-school children in a study carried out in a village
community [Taylor et al., 1988].
1.4.9.2. Contribution of respiratory viral infections to bacterial diseases or carriage
Factors proposed to contribute to enhanced susceptibility to bacterial diseases
associated with viral infections include: immunosuppression; enrichment of local
growth conditions; enhanced binding to virus infected cells. Several common viral
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infections cause some degree of immune suppression [reviewed by Jakab 1981 (a, b);
Mims, 1986; Babiuk et al., 1988J. Influenza virus infection causes impairment in the
function of alveolar macrophages [Jakab, 1982], reduction in chemotaxis of
monocytes [Kleinerman et al. 1975] and reduction in lymphocyte responsiveness and
proliferation of T-suppressor cells [Gardner, 1981]. Influenza viruses also interfere
with the chemotactic and phagocytic function of polymorphonuclear leucocytes
(PMN) [Craft et al., 1976; Larson and Blades, 1976; Larson et al. 1980; Martin et al.,
1981]. Similar effects on the function of PMN were found with RSY [Craft et al.,
1976]. The resulting immunosuppression might reduce the response to unrelated
bacterial antigens.
Certain bacteria chelate iron which is essential for their growth [Morse et al., 1988;
Chen et al., 1989]. Infections of the respiratory tract caused by viruses can result in
focal microhaemorrhages favouring growth of these bacteria. Viral infections disrupt
the lining epithelium and cause local oedema and tissue injury. These changes
predispose to bacterial invasion and jeopardize local immune functions. For instance,
local anoxia caused by inflammation decreases the oxygen-dependent bactericidal
activity of tissue macrophages while the exudate can enhance bacterial growth. Lack
of ciliary function due to destruction of cilia caused by some viruses can result in
impeded clearance of invading bacteria [Camner et al., 1973]. Viral respiratory
infection is proposed to enhance aerial dissemination of bacteria harboured by babies
[Eichenwald et al., 1961].
Binding to epithelial cells is an important step for most bacterial infections. It
depends upon a number of factors including cellular surface chemistry and presence
of specific receptors on host cells. Changes in these factors might alter the
attachment of bacteria. For instance, pharyngeal cells obtained from children with
malnutrition bound more bacteria compared with cells from healthy children
[Chandra, 1988; Chandra and Gupta, 1990]. Similarly, alteration of cell surfaces
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caused by decreased amounts of fibronectin in the respiratory mucosa in patients with
cystic fibrosis was associated with binding of bacteria to the mucosal cells which
normally do not bind those bacteria [Woods et al., 1980]. Cell lysis caused by
viruses increases the level of proteases in the lining secretions which, in parallel with
the enzymes released by some bacteria, can degrade fibronectin on the surface of
surrounding cells thus enhancing bacterial binding. The degrading effect of proteases
on fibronectin during viral infections has been described [Keski-Oja et al., 1987].
These workers have also reviewed the effect of infection of chicken fibroblasts with
Rous sarcoma virus in decreasing biosynthesis of fibronectin. Decreased level of
fibronectin on nasopharyngeal cells in hospitalized patients was associated with
increased frequency of isolation of Gram-negative nasopharyngeal flora [Murphy and
Florman, 1983].
Viral infection can affect the cells in many different ways. Invasion by viruses does
not always lead to cellular lysis; selective impairment of metabolic, physiological or
genetic functions can result from subtle, non-lethal damamge to the cells. Infection
of human PMN with a recombinant influenza A virus stimulates intracellular
phosphokinase and enhances phosphorylation of proteins. The process is, however,
decreased on subsequent exposure of the cells to the virus [Caldwell et al., 1988].
Human immunodeficiency virus (HIV) induces a glycosyltransferase in a human T
cell line resulting in neo-expression of Lewis* antigen on the infected cells. The
antigen is detected on the peripheral T lymphocytes from AIDS patients and not on
the lymphocytes from healthy individuals. The expression of the antigen on the cells
is found to be of prognostic value [Adachi et al., 1988]. Hepatitis B virus also causes
neoexpression of Lewisx molecules on the surface of Kupffer cells of the liver [Okada
and Tsuji, 1990]. Infection of CV-1 and HeLa cells with Rous sarcoma virus results
in enhanced production of a characteristic cellular protein involved in glucose
transport across the cell membrane [Peluso et al., 1978]. Hynes and Bye [1974]
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described alterations to the cell surface proteins caused by viruses and association of
these alterations with cell transformation. It has been reported that 90% of RSV
infective particles remain associated with the membrane of infected cells [Levine and
Hamilton, 1969], but fusion of the budding virus with the infected cell occurs very
rarely [Bachi, 1988]. This suggests that RSV infection of the cells results in
decreased expression of the receptors for viruses.
Glycoproteins of enveloped viruses have also been implicated in alterations of the
surfaces of infected cells [Sanford et al., 1978]. In infections by naked viruses such
as Picornaviruses, the maturation and assembly of the virion takes place
intracellularly and the viruses are released by cytolysis. In contrast, replication of
enveloped viruses, e.g., (-) stranded RNA viruses, involves the synthesis of viral
structural glycoproteins and their insertion into the plasma membrane. Nascent
virions are transported to the surface where they mature by acquiring the
glycoproteins and are extruded from the cell by a budding process. The viral
glycoproteins make aggregates displacing the host structures on the membranes. By
virtue of these biochemical changes, the viruses impart to the cells a new antigenic
specificity which could be used for recognition by the immune system. These new
antigens on the surface of cells might also provide receptor sites for other pathogens
and might be responsible for enhanced binding of bacteria to virus-infected cells
reported in some studies.
There are some enveloped viruses such as herpesviruses which assemble and mature
at the inner lamella of the nuclear membrane and are transported to the surface of the
cells through cisternae of cytoplasmic membranes and in the vesicles. These also
cause similar changes on the surface of cells.
1.5. Experimental models for examination of bacterial binding
Many experimental models have been used to investigate virus induced alterations in
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attachment and invasion by bacteria. Human volunteers are rarely used as models for
studies of bacterial pathogens. In vitro assays on human cells and cultures of cells
and organs from human sources are employed but there are some limitations.
1.5.1. Buccal and pharyngeal epithelial cells
Human buccal epithelial cells have been used in many studies of bacterial attachment
[Craven et al„ 1980; Salit and Morton, 1981; Stephens, 1989]. Easy availability of
the cells is offset by the fact that they are not uniform in size, degree of maturity or
viability. They might already have bacteria attached to their surface from oral flora
which can affect the results of binding assays. The cells are not the normal site of
attachment of bacterial pathogens. Bacteria can attach to these cells but unlike in vivo
target cells, they do not penetrate the membrane of these cells. Different samples of
buccal epithelial cells can vary in surface chemistry due to molecules from the food
taken just before sampling or to inherited differences between individuals, e.g., blood
groups. Variations in binding of bacteria to cells from the same donor have been
shown [Tramont and Wilson, 1977]. Use of buccal epithelial cells to study the effect
of virus infection on bacterial binding is further hindered by the inability of these
cells to be infected with respiratory viruses.
Pharyngeal cells can also be obtained relatively easily. Their use in in vitro bacterial
attachment assays is limited by factors described above. Pharyngeal cells, however,
are relevant to the study of the viral-bacterial association since virus-infected cells
can be obtained from virus-infected hosts.
Fainstein et al. [1980] compared bacterial
21 individuals who had nasopharyngeal
influenza virus with cells from 10 healthy
binding to pharyngeal cells obtained from
symptoms but were culture negative for
subjects infected with an experimental
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vaccine strain of influenza virus and with cells from 21 age-matched, symptom-free
controls to study the effect of viruses on bacterial binding. Increased binding of
Staph, aureus to the infected cells compared with uninfected cells was observed. In
contrast, this pattern of binding was not observed for some other bacteria used in the
assay. No comment was made about the bacterial species which might have been
present in the subjects in different groups. Evidence for infection by viruses in the
individuals with nasopharyngeal symptoms was not provided in the study.
1.5.2. Tissue/organ cultures
Nasopharyngeal tissues from adenoids [Stephens, 1989; Stephens and Farley 1991]
and nasal tissues from inferior turbinates resected from patients with non-allergic
symptoms [Read et al., 1991] were obtained for the study of pathogenesis of
N. meningitidis and H. influenzae infections. This model might accurately reflect the
events happening in natural infections, but it has disadvantages. The tissues are
difficult to obtain. The features related to genetic make up of the donor and the
disease for which the donor was treated are reflected in the resected tissue. Patients
undergoing surgery are presumably free of viral infections. So far, no attempt has
been made to infect these organ cultures with viruses in vitro.
Organs, however, can be used from animals naturally or experimentally infected with
viruses. Tracheas from mice experimentally infected with influenza virus A and
killed on 2nd, 4th or 6th day post-infection were exposed to a suspension of
radiolabelled Strep, pneumoniae for 90 minutes. Radioactivity from the tracheas of
the infected mice was found to be significantly higher than from the tracheas from
uninfected mice indicating that influenza virus enhances binding of streptococci. The
bacteria were found to be attached to flat-surfaced epithelial cells which replaced
ciliated columnar epithelial cells in the mucosa of the infected mice and to basement
membrane on the denuded areas of the tracheas as shown by elecron microscopy
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[Plotkowski et ai, 1986]. Electron microscopic findings of bacterial attachment to
the mucosa of the tracheas from uninfected mice were not reported in the study.
Organ cultures of tracheas from chinchillas infected with influenza A virus have been
used to study the effect of virus infection on the tracheal histopathology and on
binding of H. influenzae. Non-typable strains bound more effectively compared with
Hib. Increased titres of Hib were recorded in the nasal washings from infant rats that
had been inoculated with influenza A virus followed by bacteria 48 hours
post-infection [Michaels and Myerowitz, 1983]. Binding of nontypable H. influenzae
to chinchilla tracheal tissue infected with influenza A virus was decreased at 72 Im¬
post-infection [Bakaletz etal., 1988a].
1.5.3. Animal models
Animal models have also been used for the study of virus-bacterium association. A
maximum delay in clearance of Pasteurella pneumotropica from the lungs of rats
infected with Sendai virus after daily challenge with the aerosolized bacteria was
observed during 6-9 days post-infection [Jakab, 1981a].
Use of organs dissected from animals and animal models is, however, not relevant for
assessment of effect of viral infections on the bacteria causing meningitis since most
common bacteria responsible for the disease (Hib, meningococci and pneumococci)
are exclusive human pathogens. Animals, however, have been used to study isolated
events in the pathogenesis of the disease.
1.5.4. Cell culture models
Cell culture models have been used for the study of cytotoxicity caused by bacteria,
bacterial attachment, and the effect of viral infections on this attachment. Primary
cells have been employed for these studies but are difficult to establish and maintain.
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No significant difference was observed in the binding of Staph, aureus and other
bacteria causing bovine respiratory diseases to cells from bovine embryonic lung
infected with bovine parainfluenza virus [Toth and Gates, 1983]. A primary
endothelial cell culture established from newborn umblical cord was used to examine
the binding of Staph, aureus to human endothelium in the pathogenesis of bacterial
endocarditis [Ogawa et al., 1985]. Complications such as variations in the source of
the tissues and, often, pathology of the organ from which the tissue in question is
resected make the primary cell culture model less than ideal for studies of
virus-bacterium interaction.
Permanent cell lines of tumour origin are easy to handle and can be maintained
aseptically in standard conditions. Stephens [1989] reviewed the use of different
models including HeLa cells and HEp-2 cell line (human epithelial cell lines) in
studies of the binding of Neisseria species. Permanent cell lines were found suitable
for the studies. Chang epithelial cells (derived from human conjunctiva) were used to
determine the role of bacterial pili in the attachment of H. influenzae [St. Geme and
Falkow, 1990]. HeLa and Detroit cells (a human epithelial cell line) were used to
study the effect of cellular infection with measles virus and adenovirus on binding of
bacteria [Selinger et al., 1981]. Sanford et al. [1978] used MDCK cells to examine
the effect of influenza virus infection of the cells on the attachment of streptococci.
The bacteria attached to the infected cells only. The attachment could be blocked by
pre-treatment of the infected cells with an antibody to the viral glycoproteins
expressed on the surface of the infected cells indicating that the viral glycoproteins
might be the receptors for the bacteria. Staphylococci did not attach to MDCK cells
in this study; but, attachment was observed in a later study by the same group [1986].
The cells in this study were used to analyse the effect of influenza virus infection, the
effect of enzymes and changes in other conditions in the assay on the attachment of
staphylococci. The reason for the discrepancy between the two findings of the
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attachment of staphylococci to MDCK cells was not discussed in their report.
1.5.5. Detection of bacterial binding
Methods commonly used for assessing bacterial binding to cell cultures include: light
microscopy of stained monolayers of the cells [Selinger et al., 1981; Musher and
Fainstein, 1981]; fluorescence microscopy [Sanford et al., 1978]; interference
contrast microscopy [Andersson et al., 1986]; electron microscopy [Childs and
Gibbons, 1988; Stephens et al., 1983]; radioassays [Ogawa et al., 1985; Sanford et
al., 1986]; and pour plate method, counting colony forming units of bacteria in the
supernatant after incubation with cell monolayers [Ogawa et al., 1985].
Direct microscopy is simple, cheap and allows visualization of the process being
studied. It is, however, not accurate for quantitation of large numbers of bacteria or
for large experiments. Radioassays are also limited in value since the manipulation
of bacteria for the uptake of the label can affect bacterial binding. Leakage of
radioactive material from the labelled bacteria and background disturbance in
detection of radioactivity in these assays also make the assessment more complicated.
The use of electron microscopy is mainly limited to the study of mechanisms of
bacterial attachment to the cells and bacterial pathogenicity. It cannot be used to
demonstrate adherence with confidence since the results cannot be generalized due to
patchy distribution of bacteria bound to cells and the area of tissue visualized by the
micrscope is limited.
Flow cytometry has also recendy been applied in our laboratory for study of binding
of bacteria [Rahat, 1990]. The flow-cytometer can detect fluorescein-labelled
bacteria on cells. The proportion of cells with bacteria attached and mean level of
fluorescence can be obtained using this method. Although mean fluorescence
recorded on cells is proportional to the numbers of bacteria attached, it cannot be
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expressed in terms of numbers of bacteria because the level of fluorescence obtained
with one bacterium on a cell is difficult to determine accurately. The method is,
however, rapid, objective, precise and analyses a large number of cells in each
sample.
1.6. Human respiratory syncytial virus (RSV)
Although it has been suggested that infection with influenza virus might be a factor
predisposing to bacterial infections, RSV was chosen as the model for the studies
presented here for the following reasons. RSV is an ubiquitous, important viral
respiratory pathogen. The virus causes lower respiratory tract infections,
bronchiolitis and pneumonia, mainly in infants, the elderly and immunocompromised
hosts [Hall, 1980]. Reinfection is commonplace but the severity of the infection
decreases with frequency of exposure and age. RSV causes upper respiratory illness
and otitis media in adult populations and military personnel [Hers et al., 1969;
Sanford, 1975; Henderson et al., 1979]. Epidemiological studies indicate that half of
all children are infected in their first year of life and virtually all by the age of two
[Henderson et al., 1979]. Epidemics of RSV infections recorded in Washington DC
between 1957 and 1970 occurred primarily in late autumn, winter and early spring
each lasting for about 5 months [Kim et al., 1973]. A peak incidence of RSV
infection in winter and early spring was also recorded in England and Wales during
1980-1982 [Noah, 1989] and during 1989-1991 [Anonymous, 1991]. An MRC
survey over two years also suggested a high incidence of RSV infections among
children, hospitalized or in general practice, between October and March [Gardner,
1973]. This pattern fits the incidence of bacterial meningitis better than that observed
for influenza virus infection [Noah, 1989]. Figure 1.2 summarizes the relative
incidence of RSV-infection and meningitis due to Hib and meningococci in England
and Wales during 1989-1990 [Anonymous, 1991; Jones and Kaczmarski, 1991;
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Figure 1.2. Seasonal variation* In Incidence of RSV-lnfectlon and
meningitis due to meningococci and Hlb In England and Wales
during 1989-1990.
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Nazareth et ah, 1992].
Respiratory syncytial virus belongs to the genus Pneumovirus in the family of
Paramyxoviridae. It is an enveloped, large, negative stranded RNA virus,
heterogeneous in shape and size. The virus particles are pleiomorphic of
approximately 80-350 nm in diameter or filaments of up to lOum in length. The
virions assemble at circumscribed regions on the plasma membrane of the infected
cell and mature by budding during which intracellular nucleocapsid is packaged
within an envelope that is derived from the host cell membrane [Bachi, 1988]. The
envelope contains spike-like projections spaced at 6-10nm intervals composed of the
major structural glycoproteins G and F which mediate viral attachment (G) [Levine et
al., 1987] and fusion and penetration (F) [Walsh and Hruska, 1983]. These
glycoproteins are transported to the cell membrane and inserted in the lipid bilayer
[Satake et al., 1985; Walsh et al., 1989]. (See section 7.1 for details of viral
glycoproteins).
Two antigenically distinct types of RSV, designated A and B subgroups based on
variation in G glycoprotein of RSV have been recognized [Anderson et al., 1985;
Johnson et al., 1987]. The antigenic variations are shown to have significant effect
on the epidemiology of the disease. Antigenic characterization of RSV in 483
isolates in the USA and Canada obtained during 1985/1986 indicated that outbreaks
of RSV infection were not nationwide phenomena since small sections of the
community were affected by different groups of the pathogen. [Anderson et al.,
1991].
A study involving group typing of antigens of RSV-positive nasopharyngeal aspirates
from patients indicated a regular alternation in prevalence of the two subgroups. It
was also shown that the infants under 6 months were more resistant to re-infection
with the homologous than the heterologous virus. Children between 6 and 12 months
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were able to produce significant amounts of antibodies to G glycoprotein [Waris,
1991].
The role of antibodies in protection from RSV infection is variable. Specific
antibodies do not provide complete protection in adults. Hall et al. [1991]
investigated re-infections in 15 adults who had a history of natural infection by RSV
and who were challenged with the virus. Seven of them became reinfected at the
first challenge given at 2 months after the natural infection, and 2/3 were infected by
8 months during which they were challenged at the 2nd, 4th and 8th month. Maternal
antibodies (IgG) persisting in infants between 6 weeks to 5 months do not confer
protection [Gardner, 1973]. Higher serum antibody levels in infants are, however,
found to be associated with upper respiratory infection rather than lower respiratory
infection indicating that IgG might protect the lungs [Kasel et al., 1987-1988]. The
presence of antibodies in nasal secretions in adult volunteers was associated with
reduced virus shedding and upper rather than lower respiratory infection following
RSV challenge [Mills et al., 1971]. Appropriate cytotoxic T-lymphocyte responses
were associated with decreased severity of RSV infection in volunteers [Isaacs et al.,
1990]
1.7. Aims of the study
As viral infections have been proposed to contribute to susceptibility to bacterial
meningitis, the objectives of the study were:
1-to determine the relationship of secretor status and respiratory viral diseases;
2-to test the hypothesis that RSV infected cells bind more of the bacteria that cause
meningitis than uninfected cells;
3-if binding to RSV-infected cells was increased, to attempt to identify cellular
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surface component(s) associated with enhancement of bacterial binding.
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Chapter 2
General Materials and Methods
2.1. Buffers and Media
All chemicals were of analytical grade and were obtained from BDH Chemicals Ltd.,
UK unless otherwise indicated.
2.1.1. Dulbecco's phosphate-buffered saline, solution A (DPBS)
DPBS consisted of sodium chloride (136 mM), potassium chloride (2.6 mM), sodium
hydrogen phosphate (8.1 mM), potassium dihydrogen phosphate (1.47 mM), aqueous
phenol red (0.2%) at pH 7.3.
2.1.2. Phosphate-buffered saline (PBS)
PBS was composed of 0.01 M phosphate buffer pH 7.2 with 0.15 M NaCl.
2.1.3. Virus transport medium
Virus transport medium consisted of 10.8 g CMRL powder (Gibco), 4.8 g HEPES,
1.0 g NaHCOj, 100 000 unit benzyl penicillin and 40 mg gentamicin in 1 litre of
sterile water.
2.2. Reagents used in enzyme linked immunosorbent assays (ELISA) for
determination of secretor status
Following reagents were used in ELISA.
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2.2.1. Coating buffer (CB)
CB consisted of sodium carbonate (15 mM), sodium bicarbonate (35 mM) and
sodium azide (3 mM) (pH 9.6).
2.2.2. Washing buffer
Washing buffer was prepared by adding 0.1% w/v bovine serum albumin (BSA) and
0.05% (v/v) Tween-20 to PBS (pH 7.2). The buffer was used for all washing
procedures during the assay.
2.2.3. Blocking buffer (BB)
BB was prepared by adding 1% (w/v) bovine serum albumin to PBS.
2.2.4. Substrate solution
O-phenylenediamine 40 mg in 100 ml of 0.1 M phosphate citrate buffer (0.1 M
sodium hydrogen phosphate, 0.1 M citric acid, at pH 5) was used as substrate for the
enzyme conjugated to one of the reagents. The substrate was activated with 40 ul of
30% hydrogen peroxide (v/v) immediately before use.
2.3. Preparation of Sepharose beads for purification of blood group substances
2.3.1. Solutions used
2.3.1.1. Coupling buffer




Acetate buffer was composed of sodium acetate (0.1 M) and sodium chloride (1.0 M).
The solution was adjusted to pH 4 by adding acetic acid.
2.3.1.3. Carbonate buffer
Carbonate buffer was composed of sodium hydrogen carbonate (0.1 M) and sodium
chloride (1.0 M) at pH 8.
2.3.1.4. NET buffer
NET buffer consisted of sodium chloride (0.15 M), ethylenediamine tetra acetic acid
EDTA (0.04 M), TRIS (0.04 M), phenylmethylsulphonyl fluoride (PSMF) (0.02 mM)
and 0.03% sodium azide at pH 7.
2.3.1.5. Eluting buffer
Elution buffer consisted of 1 M acetic acid.
2.3.2. Antibody purification
Synsorb beads (Chembiomed Ltd., Edmonton, Alberta, Canada) with synthetic
carbohydrate determinants, Lea and Leb, linked to inert particles were used to purify
corresponding antibodies. One gram of the appropriate Synsorb beads was mixed
overnight at 4°C with 5 ml of hybridoma culture supernatant containing mouse
monoclonal anti-Lea (LM112/161) or anti-Leb (LM129/81) antibodies (provided by
Dr RH Fraser, Glasgow and West Scotland Blood Transfusion Service, Law Hospital,
Carluke, Lanarkshire, UK). The beads were washed twice with PBS by
centrifugation at 50 g for 5 min. The antibodies were eluted by mixing 5 ml of 2%
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ammonia in saline (pH 11) with the beads for 15 min at room temperature. The beads
were stored in 70% v/v ethanol at 4 °C for further use.
2.3.3. Coupling of proteins to Sepharose beads
Cyanogen bromide activated Sepharose 4B beads (Pharmacia, Uppsala, Sweden) (0.3
G) were washed in 10"3 N hydrochloric acid for 20-30 min and centrifuged at 50 g for
10 min. Samples (5 ml) containing antibodies to Lea and Leb antigens eluted from
synsorb beads (2.3.2) were freeze-dried to remove ammonia. The antibodies were
reconstituted in 5 ml of coupling buffer. Ulex europaeus lectin (UEAI) (Sigma, Pool,
Dorset, UK) (1 mg) was dissolved in 5 ml of coupling buffer. These solutions were
continuously mixed with Sepharose beads overnight at 4°C. The beads were washed 3
times with NET buffer. Unbound active sites were blocked by 1 M ethanolamine (pH
8) for 2 hr. The beads were subjected to three cycles of washings with acetate buffer
and carbonate buffer alternately for removal of non-covalently bound proteins. These
preparations were used in purification of blood group antigens from saliva.
2.4. Maintenance of HEp-2 cell line
2.4.1. Media used
2.4.1.1. Cell Growth Medium (GM)
GM consisted of Eagle's minimal essential medium (Gibco) supplemented with foetal
calf serum (FCS) (Gibco) (10%), NaHC03 (0.85 g/1), L-Glutamine (2mM),
streptomycin (200 ug/1) and penicillin (100 IU/ml). The pH of the final preparation
was adjusted to 7.4 with 1 N NaOH.
2.4.1.2. Cell Maintenance Medium (MM)
MM consisted of the same constituents as GM except the quantity of FCS was
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reduced to 1%. In some assays involving live bacteria, MM without antibiotics was
used. The medium for cells kept in 5% C02 in air contained 2 g/1 of sodium
bicarbonate.
2.4.2. Method
HEp-2 cell line (Flow Laboratories) was used in the studies involving RSV infection
of the cells and in bacterial binding assays. The cell line consists of transformed
epithelial cells originating from a human laryngeal carcinoma. The cells between
passages 400 to 450 were used in the assays. Following two rinses with DPBS, a
solution of 0.05% trypsin and 0.02% EDTA (Cell Culture Products) (2ml for a 75
cm2 flask) was applied to monolayers of the cells for 2-5 min at 37°C to prepare a
suspension for the next passage. The cells used in bacterial binding studies were
suspended by applying 1 ml EDTA (0.5%) to monolayers in 25 cm2 flask for 5-10
min at 37°C. The effect of the trypsin/EDTA or EDTA on the cells was terminated by
suspending the cells in GM or MM. Non-viable cells were detected by preparing a
dilution (1/10) of the cell suspension in 0.5% trypan blue in physiological saline
(Northumria Biological, UK) which stained these cells. Viable cells (unstained) were
counted by light microscopy using an improved Neubauer counting chamber. Cells
from freshly confluent monolayers were suspended in 1 ml of 10% dimethyl
sulphoxide (DMSO) (Sigma) in GM and stored in liquid nitrogen following gradual
cooling to -70°C. Frozen cells were resuscitated by rapid thawing at 37°C for further
use.
2.5. Preparation and standardization of respiratory syncytial virus (RSV)
2.5.1. Growth of viruses
Edinburgh strain of RSV [Ogilvie et al., 1981] was used in these assays. Stocks of
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virus from 5th to 7th passages were prepared as follows.
One-day-old sub-confluent monolayers of HEp-2 cells were infected with RSV at
multiplicity of infection (M.O.I.) of 2-3 infectious particles per cell for one hr. The
monolayers were maintained in MM for 48-72 hr at which time the cells began to
fuse due to the RSV-infection. About 4/5 of the medium in the flask was discarded
and the flask was frozen at -70°C and then thawed to lyse the cells. The suspension
was centrifuged at 700 g for 10 min to get rid of large cell debris. Aliquots of the
supernatant were stored at -70° C for further use.
2.5.2. Plaque assay
2.5.2.1. Solutions
Overlay medium (O/L) was prepared by adding methyl cellulose from a stock
preparation (3% w/v methyl cellulose in Hanks' salt solution) (25%) and NaHC03 (to
a final of 2 g/1) to MM.
Staining solution was used to examine cell monolayers for syncytia and plaque
formation. This solution contained crystal violet (0.13%) and formalin (5% v/v) in
normal saline.
2.5.2.2. Method
Cell monolayers were grown in 24-well tissue-culture plates (Costar) for 24 hr.
Ten-fold dilutions of the virus suspension were distributed to wells in quadruplicate
(200 ul/well) and adsorbed to monolayers for 1 hr at 37° C. The supernatant was
removed from the wells and 1 ml of overlay medium added to each well. The plates
were incubated in 5% CO2 at 37°C for 3-4 days until syncytia/plaques appeared in the
monolayers. The monolayers were fixed and stained with the crystal violet stain for
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20 min and washed with tap water. The monolayers were examined by inverted light
microscopy for syncytia and plaques.
2.5.3. Detection of RSV infected cells
Samples of cells in monolayers and suspension were examined for the proportion of
RSV-infected cells by fluorescence microscopy and flow cytometry.
2.5.3.1. Fluorescence microscopy
One day old monolayers of HEp-2 cells on glass coverslips (13 mm) were infected
with different M.O.I, of RSV for 24 hr. Monolayers were fixed with chilled acetone
(BDH) for 5 min and reacted with mouse monoclonal antibody to F glycoprotein of
RSV (1/100) (20 ul/coverslip) (kindly supplied by Prof. P.J. Watt, Southampton
University) for 30 min at 37°C. After washing 3 times with PBS, 20 ul of
FITC-labelled anti-mouse antibody (1/50) (Fab fragment, absorbed with human
serum protein) (Sigma) were added to each coverslip for 30 min. The monolayers
were washed 3 times, dried and mounted with 50% glycerol in PBS. They were
examined by ultraviolet microscopy for the proportion of fluorescent cells present.
2.5.3.2. Flow cytometry
Monolayers of HEp-2 cells were infected with different M.O.I, of RSV for 24 hr.
The cells were suspended as described in section 2.4.2. The cells in suspension (200
ul) (1 X 106/ml MM) were reacted with the same antibodies as above. The final
concentration of anti-F antibody was 1/100 and that for FITC-labelled anti-mouse
immunoglobulin antibody was 1/200. The cells were washed 3 times with PBS by
centrifugation at 680 g for 7 min. The cells were suspended in 200 ul PBS and fixed
with 100 ul 1% buffered paraformaldehyde. The proportions of fluorescent cells and
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mean channel fluorescence of the cells were determined by flow cytometry (see
section 2.7).
2.6. Bacteria
Meningococci (3 strains), H. influenzae (5 strains) (Tables 2.1 and 2.2) and
Staph, aureus (1 strain) were used in the assays. Hib isolates from Icelandic
children were kindly provided by Dr. K. Jonsdottir, University of Iceland.
Serogroups, serotypes and subtypes of meningococcal isolates were determined by
Dr. R.J. Fallon, Meningococcal Reference Laboratory, Scotland.
2.6.1. Media
Modified New York City medium (MNYC)
This medium was prepared as described by Young [1978]. GC medium base (Difco,
UK) was supplemented with 10% (w/v) horse blood lysed by saponin (0.5% w/v),
yeast dialysate (2.5% w/v), glucose (0.1% w/v), lincomycin (1 ug/ml), colistin (6
ug/ml), amphotericin B (1 ug/ml) and trimethoprim lactate (6.5 ug/ml).
Boiled blood agar (BBA) was prepared by heating sterile blood (10% v/v) in nutrient
agar.
GC-plus medium contained GC agar supplemented with proteose peptoneNa 3 (15
gm/1), corn starch (1 gm/1) dibasic potassium phosphate (4 gm/1), monobasic
potassium phosphate (1 gm/1) and sodium chloride (5 gm/1).
2.6.2. Maintenance and storage of bacteria
Bacterial cultures were prepared by reconstituting lyophilized strains in distilled
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Table 2.1. Isolates of Neisseria meningitis examined
Serogroup Serotype Subtype Source
C 2b PI .2 patient
NG - PI.9 carrier
Y* 14 PI .2 Carrier
* This strain was used in both pilate and non-pilate
forms. NG non-groupable
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14 -- — — Edinburgh
20 4b 1 NT 1 Reykjavik
21 1 1 2 9 Reykjavik
25 12 1 1 1 Reykjavik
29 1 — — — Reykjavik
NT - non-typable
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water and plating them on appropriate media. Meningococci were grown on MNYC
medium for most of the binding assays and H .influenzae on BBA. For some
experiments, meningococci were grown on BBA or GC medium to examine the effect
of the medium on bacterial binding. Meningococci for the latter part of the study
were grown on BBA. An overnight growth of meningococci and 48 hr culture of H.
influenzae at 37° C in 5% C02 were used in the assays. The bacteria were suspended
in soya broth containing dextrose (0.25%) (DIFCO) and stored at -20°C. Subcultures
were prepared from these frozen stocks.
The bacteria were harvested, washed 3 times by centrifugation at 2500 g for 10 min.
They were resuspended in MM without antibiotics for use in the binding assays with
cells in monolayers or were labelled with a fluorescent dye, washed 3 times and
suspended in MM without antibiotics for use in assays with cells in suspension (see
below).
2.6.3. Determination of bacterial concentration
For each strain, the bacterial concentration was determined by optical density (OD) at
540 nm and by light microscopy with a Thoma counting chamber. The range of
readings of OD having a linear relationship with the counts for each strain is given in
Fig 2.1. The bacterial suspensions were adjusted to provide a range of ratios of
bacteria per cell for use in the assays.
2.6.4. Labelling of bacteria
Fluorescein isothiocyanate (FITC) (Sigma) was used for labelling the bacteria in most
assays. The solution was prepared as described by Rahat [1990]. FITC (400 ug) was
dissolved in 1ml of buffer containing sodium carbonate (0.05 M) and sodium chloride















The washed bacterial pellet from two culture plates was suspended in 2 ml of FITC
solution by gentle shaking at 37°C for 20 min. The FITC-labelled bacteria were
washed three times with DPBS and resuspended in MM without antibiotics. The
bacterial concentration was adjusted as described above.
Some aliquots of bacteria were also labelled with rhodamine 123 (Eastman Organic
Chemical, Rochester) to compare the efficiency of the two fluorescent dyes.
Rhodamine was dissolved in distilled water (Img/ml) and diluted in equal volume of
MM before use. Bacterial pellets from 2 plates were incubated with 2 ml of
rhodamine solution for 30 min or 1 hr (see 5.3.3.1 for detail).
2.7. Detection of bacterial binding by flow cytometry
Flow cytometry involves sensing particles as they move in a liquid stream past a laser
beam. Patterns of scattered light carrying information about size, granularity and
fluorescence on particles are gathered by sensors appropriately placed around the
stream. The information is displayed in histograms having various assigned
parameters, e.g., size. Setting up of the system involves placing a cursor in a
histogram (see below) to demarcate fluorescent populations from non-fluorescent
ones and adjusting the photosensitivity of the machine.
The cell samples were analysed with an EPICS-C (Coulter Electronic, Luton, UK)
equipped with a 5 watt laser with a power output of 200mWat 488 nm. A bitmap was
drawn to enclose the main population of the cells from a display on a histogram
showing the signals of size and granularity of the cells. The percentage of the
fluorescent cells in the main population was obtained from a one-parameter histogram
(H-%) with a logarithmic scale. The cursor was placed at channel 55 of H-%. The
photosensitivity of the machine was adjusted in such a way that about 2% of the cells
in non-fluorescent samples used as control for each experiment were assessed as
fluorescent with reference to this channel. The mean values of fluorescence from
positive cells were acquired from a one-parameter histogram measuring fluorescence
on a linear scale.
The data obtained from test samples recorded on H-% histograms were compared
with that from a control sample for each experiment using the immunoanalysis
program (Coulter, UK). This computer programme subtracts the values of control
population from the test population at each channel. For each sample, a binding
index (BI) was calculated by multiplying the percentage of fluorescent cells obtained
from the immunoanalysis and the mean of fluorescence.
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Chapter 3
Secretor status and viral infection
3.1. Introduction
Susceptibility to a variety of bacterial and superficial fungal infections is associated
with the genetically controlled inability of individuals to secrete the water soluble
form of their ABO blood group antigens into body fluid (non-secretion).
Non-secretors are also over-represented among patients with some autoimmune
diseases for which infectious triggers have been proposed (Table 1.3). Associations
between ABO blood groups and viral infections have also been investigated.
McDonald and Zuckerman [1962] found a substantial relative excess of blood group
O patients and a corresponding deficiency of blood group A patients among 2,000
army personnel with infection by H2N2 strain of influenza A virus during 1956 to
1961. An opposite trend of blood groups for an association with infection due to
adenovirus was noted in the group. An association between infection with another
strain (H3N2) of influenza A virus and blood group B was also reported [Mackenzie
and Fimmel, 1978].
Repeated exposure of a population to a virus will result in development of specific
immunity in the individuals. This might obscure any effect associated with blood
groups to viral infections in non-immune individuals. Potter [1969] found no
difference in the incidence of infection with different strains of influenza virus and
adenovirus among people of different blood groups in a population which was
repeatedly exposed to epidemics of these viral infections. Evans [1975] found no
association between ABO blood groups and infection due to influenza A and B
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viruses, parainfluenza virus or adenovirus in a prospective study of 925 recruits.
If viral infections can contribute to susceptibility to meningococcal disease, this
might be due to non-secretors being at increased risk of viral infections. So far,
associations between secretor status and viral infections have not been studied. In
this study, the hypothesis that non-secretors might also be at increased risk of viral
infection was examined.
Because the quantities of material available from patients with viral diseases were too
small to determine secretor status by the usual haemagglutination inhibition method
[Mollison.1979], an enzyme linked immunosorbent assay (ELISA) was developed to
detect Lewis blood group antigens in the specimens. Non-secretors express only
Lewis3 (Lea) and secretors express Lewisb (Leb) and variable amounts of Lea on their
red blood cells and in their body fluids (Table 1.1).
3.2. Materials and methods
3.2.1. ELISA for Lewis antigens
Lea and Leb blood group antigens were detected in body fluids by an ELISA (Fig
3.1). Wells of polystyrene microtiter plates (Dynatech, Billinghurst, Sussex) were
coated overnight at 4°C with 100 ul of monoclonal anti-Lea diluted 1/25 or
monoclonal anti-Leb diluted 1/20 in coating buffer (2.3.2). All further procedures
were carried out at room temprature except when stated otherwise. The wells were
washed 3 times with washing buffer and blocked with 150 ul of blocking buffer for
15 min. The buffer was removed and the wells were washed 3 times.
Dilutions of saliva from known secretors and non-secretors were used in each plate as
controls. The test wells contained 100 ul of the specimens (saliva, nasal washings or
respiratory secretions) which had been boiled for 30 min to inactivate enzymes,
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Figure 3.1. ELISA for detection of Lewis antigens.
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bacteria or viruses. Samples of saliva were diluted 1/100 in blocking buffer for
detection of Lea, and 1/20 for detection of Leb. The more dilute nasal washings or
respiratory specimens were diluted 1/10 in blocking buffer to detect Lea antigens but
were used undiluted to detect Leb antigens.
After incubation for 60 min, the wells were washed 3 times and 100 ul of polyclonal
goat anti-Lea antibody (Behring, Marburg, West Germany) (1/500 in blocking buffer)
or 100 ul of anti-Leb antibody (Behring) (1/250) were added to the wells of the
appropriate plates. After 30 min incubation, the wells were washed 3 times, and 100
ul of horseradish peroxidase-conjugated donkey anti-goat immunoglobulin (Scottish
Antibody Production Unit, Carluke, Lanarkshire) (1/250 in blocking buffer) were
added. After overnight incubation at 4°C, the plates were washed three times and 100
ul of activated substrate solution were added to each well. The colour was allowed to
develop for 10-15 min, and the reaction was stopped by adding 50 ul of stopping
solution to each well.
Absorbance at 490 nm was measured with an ELISA plate reader (MR 700)
(Dynatech). Samples were tested in duplicate and readings were averaged. The
averaged reading obtained for the test samples was compared with that of the controls
added in the same plate. Values equal to or above that of control were considered to
be positive. The subjects from whom the samples were obtained were classified as
non-secretors if only Lea was detected or as secretors if Leb or both Lea and Leb
antigens were detected.
3.2.2. Samples and controls
To assess the method, the results obtained by the ELISA were compared with those
obtained by a haemagglutination inhibition assay (HAI) for 1155 saliva specimens
collected during the Stonehouse study [Blackwell et al., 1989c], Nasal secretions
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were collected from 26 members of staff whose secretor status and Lewis blood
group antigens had been previously determined. Secretions were collected with
cotton wool swabs and inoculated into virus transport medium. The transport
medium was assayed for presence of Lewis antigens. Nasal washings (n=872)
obtained from volunteers as part of other studies at the Medical Research Council's
Common Cold Unit were also tested to determine if the Lewis antigens could be
detected in diluted nasal secretions. They were originally obtained from the
volunteers for assessment of secretory antibodies and stored at -20°C for 4-5 years.
As there is no association between sex and secretor status or sex and Lewis blood
group [Mourant et al., 1976], the distribution of Lea and Leb antigens in the local
population was determined with red blood cells from 363 women attending antenatal
clinics at the Royal Infirmary, Edinburgh, by standard tube agglutination method with
the monoclonal anti-Lea and anti-Leb antibodies referred to above in 10% Dextran
and 2% BSA [Scottish National Blood Transfusion Service]. The results were
compared with those of a previous study of the local population in which secretor
status of 334 blood donors was determined from saliva by HAI [Kinane et al., 1982].
Specimens (584) sent to the Regional Virus Laboratory, mainly from hospitalized
patients (age group 1 month to 90 years) with symptoms of viral disease were used in
this study. These were aspirated nasal or respiratory secretions or throat swabs
inoculated into virus transport medium (2.1.3) which had been stored at -70°C
following culture for virus.
The sources of specimens used in this study are summarized in Table 3.1. The results
for local population and test specimens were compared by X2 test incorporating
Yates' correction factor. Odds ratios and 95% confidence intervals (CI) were
calculated by the exact method.
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Local antenatal clinic Blood 363
Local antenatal clinic Saliva 334
Stonehouse study Blood & saliva 1155
MRC Common Cold Unit Nasal washings 872










3.3.1. Assessment of the ELISA for detection of Lewis antigens in the body fluids
Lea, Leb or both antigens were detected by the ELISA in 1089 of the 1155 (94.3%)
saliva specimens for which secretor status had been determined by HAI. The results
of ELISA for Lewis antigens and HAI agreed for 1058 (97%) of 1089 Lewis positive
specimens, 796 Leb antigen positive (secretors) and 262 Lea antigen positive
(non-secretors). The results for the two assays disagreed for 31 samples; 27 were
positive for Lea only (non-secretors) by the ELISA but secretors by HAI and 4
specimens were Leb positive (secretors) by the ELISA but non-secretors by HAI.
Lewis antigens could not be detected by the ELISA in 66 specimens (5.7%): 30 were
from secretors and 36 from non-secretors as determined by HAI. Lewis phenotype
determined by agglutination of red cells for 124 of these donors agreed with the
results of the ELISA for 96% of those tested. The ELISA correctly identified the
Lewis antigen present in nasal secretions of all 26 laboratory staff. Among the 872
nasal washings obtained from the Common Cold Unit, Lewis antigens were detected
in 854 (97.9%): Lea antigen in 233 (26.7%); Leb in 621 (71.2%); and no Lewis
antigen in 18 (2.1%). The results do not differ from the distribution of these
phenotypes in most northern European populations [Mourant et al., 1976].
3.3.2. Lewis phenotypes of the local population
Among 363 blood specimens from the antenatal clinic (Table 3.1) for which the
Lewis antigens were determined, 28% were Lea and 72% Leb. These results were not
significantly different from the proportion of non-secretors (26.6%) and secretors
(73.4%) determined in a previous study by HAI tests of 334 saliva samples from local
blood donors [Kinane etal., 1982].
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3.3.3. Lewis phenotype of patients with viral illnesses
In 192 of the 584 (33%) patients' specimens examined by ELISA, there was not
enough Lewis antigen detected for definite classification. There were 81 borderline
ELISA readings, and in 111 no antigen was detectable. Among the 192 specimens
that were borderline or Lewis-negative, no virus was isolated from 38 (20%). Among
the 392 specimens in which either or both Lewis antigens were definitely detected, no
virus was isolated from 36 (9%) cases P<0.0005). The proportion of
unclassifiable specimens did not vary significantly with respect to isolation of any
particular virus. As the specimens giving negative and borderline results for Lewis
antigens could not be classified as being from secretors or non-secretors, they were
eliminated from further analysis.
Some of the specimens (n=60) which were positive for Leb and for RSV, rhinovirus
or parainfluenza virus (20 from each group) were deliberately freeze-thawed at least
twice. They were then examined in the ELISA to investigate the effect of
freeze-thawing on the detection of the Lewis antigens. These samples were also
tested in the ELISA for H antigen for confirmation of the results.
The repeat-ELISA detected Lea in some previously Lea-negative samples. Leb was
detected in fewer samples in the repeat-assay compared with the first test. Not all the
samples positive for Leb also showed H activity (Table 3.2).
Isolation of viruses ffom Lea/non-secretors and Leb/secretors is compared in Table
3.3. Compared with the local population, there was a significantly higher proportion
of secretors among subjects from whom the following viruses were isolated:
Influenza A virus (P<0.05), rhinovirus (P<0.01), respiratory syncytial virus (RSV)
(P<0.0005), and echovirus (P<0.0005). Although 11 of 13 specimens with influenza
B virus were secretors, the numbers were too small to be significant. This pattern
was not observed for the 67 specimens from which parainfluenza virus was isolated
or the 36 specimens from which no virus was isolated. In these two groups the
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Table 3.2. Effect of freeze-thawing on detection of
Lewis and H antigens in samples of nasopharyngeal
washings determined by ELISA



































































































































proportions that were Leb antigen positive (secretors) and Lea antigen positive
(non-secretors) were similar to that of the local population.
3.4. Discussion
3.4.1. Validation of method
Determination of Lewis phenotype is a good control for the HAI for ABO antigens
which has been the standard method for determination of secretor status. Agreement
between the Lewis phenotype and HAI for 1089 specimens was 97%. "False
secretors", Lea type by ELISA but secretors by HAI predominated among
mismatched pairs (27/31, 87%). Results of previous studies indicate that these results
are most likely due to contamination of saliva by blood owing to poor oral hygiene or
periodontal disease among these subjects [Blackwell et al., 1989c]. Dilution of small
samples to provide enough material for the haemagglutination inhibition test is
probably the source of the small proportion (0.4%) of "false" non-secretors who are
of Lebphenotype but non-secretors by HAI.
The ELISA method eliminates the problems of contamination of non-secretors' saliva
by red cells and it can be carried out on smaller volumes than those needed for HAI.
The method detected Lewis antigens in 854/872 (98%) specimens from the Common
Cold Unit, indicating that it can be used to assess these antigens in diluted nasal
secretions
3.4.2. Results from patients with viral disease
The nasal washings from volunteers at the Common Cold Unit were originally
collected for determining secretory antibody titres and were frozen soon after
collection which would preserve the Lewis antigens; analysis of the results found the
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expected (2%) proportion of specimens negative for Lewis antigen. The high
proportion of specimens from patients in hospital with viral illness for which
borderline readings were obtained or no Lewis antigen was detected might be due, in
part, to collection techniques, time taken for transportation and processing, and
repeated ffeeze-thawing of the specimens.
There was a significantly higher proportion of unclassifiable specimens from which
no virus was isolated (20%) compared with the proportion of specimens in which
Lewis antigens were definitely detected but from which no virus was isolated (9%) (P
< 0.0005). The proportion of unclassifiable specimens was not greater among the
very young age group (<24 months) from whom nasopharyngeal secretions are
usually obtained. Although Lewis antigens were correctly identified in all the
samples of transport medium inoculated with nasal swabs from 26 laboratory staff,
secretions provide a larger quantity of material for isolating virus and detection of the
Lewis antigens.
Repeated freeze-thawing could also affect the quality of samples due to degradation
of the blood group antigens (Table 3.2). Blood group antigens cannot be reliably
detected in saliva kept overnight at room temperature (personal communication). The
results obtained with these specimens might reflect degradation of the antigens due to
delays in their transportation to the laboratory.
The terminal fucose of Leb added by the transferase encoded by the secretor gene is
also recognized as the H determinant in the ELISA for detection of H. The assay for
H determinant is different from the ELISA for Leb; it is more sensitive and the
antigens in the samples are directly coated onto the surface of the wells instead of
being captured by antibodies as in the ELISA for Lewis antigens. H antigen was
detected less frequently in specimens than Leb antigen in the repeat assays (Table
3.2). This might reflect some enzymatic changes in the specimens due to repeated
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freeze-thawing affecting the coating of the antigens. The possible conversion of
specimens from Leb to Lea by freeze-thawing cannot adversely affect the results in this
study since Leb positive specimens were over-represented in this data.
Previous studies found non-secretion of ABH antigens to be associated with various
bacterial diseases and superficial yeast infections and with carriage of some
pathogenic bacteria or yeasts [Burford-Mason et al, 1988; Blackwell et al, 1989b]. In
contrast, the findings in the present study indicate that secretors were
over-represented among the hospitalized patients with respiratory illness due to
influenza A virus, rhinovirus, or RSV. Secretors were also significantly
over-represented among those from whom echoviruses were isolated; these patients,
however, had various illnesses including meninigits, fever, and vomiting. An
increase in the proportion of secretors was not associated with isolation of
parainfluenza virus or with the group of individuals from whom no virus was
isolated.
In another study [Blackwell et al., 1991], a similar increase in the proportion of
secretors (88%) was identified in a group of 26 individuals who had acquired human
immunodeficiency virus (HIV) by heterosexual intercourse compared with 70%
secretors among 191 patients who acquired the infection by intravenous injections or
homosexual intercourse. In contrast, there were only 46% secretors in a group of 28
HIV negative individuals who were at risk but who had not acquired the virus
through heterosexual intercourse. This finding suggests that the heterosexual
secretors are at a higher risk of the infection and that non-secretion is protective.
The hypothesis that viral respiratory tract infections might be associated with
non-secretors was disproved. The following hypotheses were proposed to explain the
associations between secretion and respiratory viral disease.
(1) There is evidence that Lea antigen present in greater amounts on epithelial
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surfaces of non-secretors might be one of the receptors for N. meningitidis [Rahat,
1990]. Binding of staphylococci was significantly correlated with the amount of Lea
antigen expressed on buccal epithelial cells of secretors and non-secretors [Saadi et
al., submitted for publication]. The association of viral disease with secretors
suggests that Leb antigen present only in secretors or the higher levels of H (type 1
plus type 2) in secretors might be receptors for the viruses. H-type 1 and Leb antigens
are present in the secretions as well as on the surface of the epithelial cells. The
antigens in the secretions might inhibit the viral attachment to the cells, but, as these
molecules can still adsorb to cells, the net effect of the virus-blood group antigen
interaction might be an enhancement of the attachment.
(2) There is some evidence that galactosyltransferases are present on the surface of
epithelial cells [Davis et al., 1984], Mandrell et al. [1988] demonstrated structures
with blood group specificities on bacteria ofNeisseria species and proposed a role for
glycosylation of these structures catalysed by cell surface enzymes in bacterial
adhesion. Presence of comparable enzymes on cell surfaces that interact with the
viral proteins might be a susceptibility factor.
(3) Arendrup et al. [1991] demonstrated that antibodies to blood group A antigen
inhibited HIV grown in lymphocytes from blood group A donors but not from donors
of blood group B or O. Although the immune interaction of HTV from hosts with
other blood groups is not known, the finding suggests that the shed viruses can
acquire host glycoproteins. This is further supported by presence of high amounts of
HLA-DR antigens in the envelope of HTV grown in HLA-DR-positive cells [Schols et
al., 1992]. Presence of natural antibodies such as anti-Leb in non-secretors might be
protective against the virus infection passed from a secretor contact. An association
between ABO blood groups and HIV has not been found.
(4) The association of secretors with viral respiratory tract infections might be related
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to the severity of the illness in these patients since the samples tested in the study
were from hospitalized patients. The following possibilities are considered based on
this observation:
(a) Viruses uniquely depend upon cellular metabolic functions. Addition of sugars to
glycoproteins of viral origin is catalysed by cellular enzymes. Lack of glycosylation
of viral proteins might result in altered infectivity of the viruses. A single mutation in
avian H5N2 influenza virus associated with loss of a specific oligosaccharide side
chain is responsible for increased virulence of the virus [Kawaoka et al., 1984].
Normal bovine and mouse sera contain a lectin, termed b inhibitor, which inhibits the
infectivity of H3N1 strain of influenza virus. A single mutation in this strain
resulting in loss of a potential glycosylation site was associated with development of
resistance of the virus to these sera [Anders et al., 1990]
Lack of sugars might have deleterious effects on the infectivity of viruses. Enzymatic
removal of only few very accessible oligosaccharide side chains from RSV results in
a 76% to 98% reduction in infectivity [Lambert, 1988]. Inhibition of N- or
O-glycosylation reduces the infectivity of a variety of enveloped viruses [Leavitt et
al., 1977; reviewed by Grubber and Levine, 1985]. Virus infections have been shown
to induce host cell enzyme genes not normally expressed by the cell [Arendrup et al.,
1991]. Secretors might be at a particular disadvantage due to the presence of an
additional enzyme (a fucosyltransferase from the secretor gene) in their cells.
Fucosylation of viral proteins by this enzyme might be critical in viral replication,
infectivity or spread of infection. If this is the case, the initial attachment of viruses
and subsequent mild infection might not be affected by secretor status. In the study
reported here, the viral diseases found to be associated with secretion belonged to a
heterogeneous group suggesting factors other than a common receptor for different
viruses.
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(b) An important factor common to most viral infections is cytolytic immunity.
Severe infection in volunteers challenged with RSV appeared to be associated with
low CTL response [Isaacs et al., 1990]. Loci encoding proliferation and
differentiation molecules for immune cells, CD23, CD33, a protein from the LYL1
locus, and the secretor genes are all located on chromosome 19. A transcription
factor from the TCF3 locus, an enhancer of kappa chain production, is also located on
this chromosome [Ropers and Pericak-Vance, 1990]. A linkage between these loci
and the locus for the secretor gene has not been described. The only known linkage
between the secretor gene and genes involved in the immune system is that with the
gene for the third component of complement [Elberg et al., 1983]. If a genetic
linkage between the secretor gene and the genes involved in the cytotoxic
T-lymphocyte response existed, this might be responsible for the association between
secretors and viral infections.
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Chapter 4
Inhibition of respiratory syncytial virus infection by
purified blood group antigens
4.1. Introduction
Cellular receptors for respiratory syncytial virus (RSV) have not so far been
identified [Lentz, 1990]. Secretion of ABH blood group antigens has been
significantly associated with disease caused by RSV (P<0.0005) (chapter 3).
Epithelial cells of secretors bind significantly more Ulex Europeus (UEAI) lectin than
cells of non-secretors [Rahat et al., 1990]. The lectin binds to fucose-containing
molecules and fucose is the immunodominant sugar found on H-type 1 and 2 and Leb.
While type 2 ABH antigens are part of the structure of the cells, it was not known
whether HEp-2 cells used for studies of viral infection express Lewis and H blood
group antigens. In this chapter, the hypothesis that Leb and/or H-type 1 antigen might
be the receptors for the virus was tested. If so, the virus attachment might be
inhibited by the antigen(s) in soluble form.
4.2. Materials and methods
4.2.1. Detection ofH and Lewis antigens on HEp-2 cells
4.2.1.1. Fluorescence microscopy
Monolayers of HEp-2 cells grown on cover slips were fixed with chilled acetone
(BDH) for 5 min and washed 3 times with PBS. After drying, 20 ul of monoclonal
antibodies, anti-Lea, anti-Leb (2.3.2) and anti-H2 (Lm92/90) [Machie et al., 1984],
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neat or diluted 1/5 in PBS, were added to the coverslips for 30 min at 37°C. After
washing 3 times, 20 ul of fluorescein isothiocynate (FITC)-labelled anti-mouse
immunoglobulin antibodies (1/50) (Sigma) were added to the coverslips for 30 min at
37°C. UAEI conjugated with FITC (Sigma) (50 ug/ml) was added in 20 ul volume to
some coverslips under the same conditions. The coverslips were washed 3 times with
PBS and dried. They were mounted with 50% glycerol in PBS and examined by
ultraviolet microscopy and the fluorescence of the cells scored.
4.2.1.2. Determination of blood group antigens by Row cytometery
Suspensions of HEp-2 cells were prepared at 1X109 cells/ml in MM. These heavy
suspensions were kept at 37°C for 2 hr to give time for the cells to secrete and adsorb
blood group antigens before proceeding further. The count was then adjusted to
lxl06/ml. The cells were first incubated with the neat, 1/5 or 1/10 dilutions of
anti-Lea, anti-Leb or anti-H2 for 30 min at 37°C. The binding of the antibodies to the
cells was assessed by incubating the cells with FITC-conjugated anti-mouse
immunoglobulin antibodies (Sigma) (1/200). FITC-conjugated UEAI (20 ug/ml) was
used for some of the samples to detect the total amount of H antigens (H-type 1 and
2) on the cells. HEp-2 cells were compared with buccal epithelial cells (BEC) of
secretors for presence of Leb and H and with BEC of non-secretors for presence Lea.
In a separate set of experiments, a direct immunofluorescence technique was used to
detect the antigens. Suspensions of HEp-2 cells prepared as above (200 ul) were
incubated with a neat or 1/5 dilution of FITC-labelled monoclonal anti-Lea, anti-Leb
or anti-H2 [Rahat, 1990] for 30 min at 37°C. The cells were washed 3 times with
DPBS, suspended in 200 ul DPBS and fixed with 100 ul 1% buffered
paraformaldehyde. The samples were analysed on an EPICS 'C' flow cytometer for
the percentage of fluorescent cells and the mean fluorescence.
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4.2.2. Purification of blood group antigens
Blood group substances with Lewis3, Lewisb and H type 1 specificities were purified
from saliva.
The Method described by Rahat, [1990] was modified to purify blood group antigens
from samples of saliva obtained from non-secretors (Lewis3), secretors (Lewisb) and
Lewis negative, blood group O secretors (H-type 1). The samples (20 ml) were
boiled and centrifuged at IX103 g for 20 min. The supernatant was freeze-dried and
reconstituted in 5 ml of distilled water. The reconstituted solutions were added to
appropriate Sepharose beads conjugated with monoclonal anti-Le3, anti-Leb or UEAI
(2.3.3) and incubated overnight at 4° C. The beads were washed 3 times with NET
buffer by centrfugation at 50 g for 7 min. The antigens were eluted from the beads
with 3 ml of 1 M acetic acid added for 10 min. The antigen solutions were dialysed
against PBS for 48 hr, sterilized by boiling for 10 min and stored in 200 ul aliquots at
-20°C until used in virus inhibition studies.
4.2.3. ELISA for detection of purified antigens
ELISA described in section 3.2.1 was used to compare the concentrations of the
Lewis antigens in the affinity purified dialysates and saliva samples.
Detection and quantification of H antigen in the dialysate was also carried out with an
ELISA (Fig 4.1). The composition of the buffers used in the experiment are given in
section 2.2. The wells of the polystyrene plates were coated overnight at 4°C with
100 ul of PBS or 10-fold dilutions of the samples and control saliva in sodium
carbonate buffer (50 mM, pH 9.6). All further procedures were carried out at room
temperature. Washing buffer was used for washing throughout. After 3 washes, the
wells were incubated with blocking buffer for 15 min. After 2 more washes, 100 ul
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of biotin-labelled UEAI (Sigma, Poole, Dorset, UK) (5 ug/ml in blocking buffer)
were added to each well for 30 min. After washing 3 times, 100 ul of
streptavidin-biotinylated horseradish peroxidase complex (Amersham, Amersham,
UK) diluted 1/100 in blocking buffer were added to the wells for 20 min. After 3
washes, 100 ul of activated substrate solution were added to each well. The reaction
was terminated after 5-10 min by 50 ul of 12.5% H2S04. The colour changes were
measured on an ELISA plate reader (MR 700) (Dynatech).
4.2.4. Virus inhibition studies
One-day old freshly confluent layers of HEp-2 cells grown in 24-well tissue culture
plates in 5% C02 in air were used in the assays. Infectious particles of RSV
(Edinburgh strain) [Oglivie et al., 1981] were incubated with different antigen
preparations described below and adsorbed to cell monolayers for 60 min at 37°C in
5% C02. The supernatant was removed and the culture plates incubated in overlay
medium for 3-4 days until cytopathic effects (CPE) (syncytia and plaques) appeared
in the monolayers. The monolayers were fixed and stained by crystal violet stain and
examined for CPE.
4.2.4.1. Incubation of viruses with antigens
4.2.4.1.1. Affinity purified antigens
Virus suspensions containing 200 plaque forming units (p.f.u.) per 100 ul were
incubated with an equal volume of purified blood group antigens or PBS as control at
37°C for 60 min. Each sample was diluted with 600 ul of MM. The diluted virus
suspensions were added in 200 ul volumes/well to 4 wells for each antigen and the
viruses allowed to adsorb to cell monolayers. In some wells, MM or the antigen




The glycoconjugates listed in Fig 4.1a consisted of blood group antigens purified
from human milk conjugated with human serum albumin (Biocarb). The
glycoconjugates were diluted in distilled water to lmg/ml which contained
2-2.5X10"4 M of the glycoproteins. Virus suspensions (100 ul) containing 1000 p.f.u.
of RSV were incubated with 20 ul of the glycoconjugate preparations under the same
conditions used for antigens purified from saliva. The supensions were diluted with
1500 ul of MM and distributed to wells (200 ul/well) and the virus allowed to adsorb
to cell monolayers as described above.
4.2.4.1.3. Saliva samples
Incubations of viruses with boiled saliva from secretors and non-secretors were also
performed. Saliva samples (20 ml) were boiled for 20 min to inactivate antibodies,
enzymes, bacteria and viruses and centrifuged at 1000 g for 10 min. The supernatant
was diluted in an equal volume of MM. Virus suspensions containing 200 p.f.u. per
100 ul were incubated with equal volumes of diluted saliva or PBS control at 37°C
for 60 min. Each sample was diluted with 600 ul of maintenance medium (MM) and
distributed (200ul/well) as described above.
4.2.4.1.4. UEAI
Doubling dilutions of UEAI ranging from 1/500 to 1/8000 in MM were incubated
with the virus suspensions and the viruses were adsorbed to the cells as described
above.
4.2.4.1.5. Synsorb beads with blood group specificities









Figure 4.1a.Lewis and H blood group antigens purified from human
milk and conjugated to human serum albumin (HSA)
through a spacer acetylphenylendediamine . Each mole of HSA
contains 10-20 moles of oligosaccharide moieties. (Symbols as in
Figure 1.1).
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1 or H-type 2 determinants. The beads (30 mg) were suspended in absolute alcohol
for 30 min. They were washed 3 times with PBS by centrifugation at 50 g for 5 min.
Virus suspensions (200 p.f.u. in 250 ul) were incubated with the beads for 60 min at
37°C with gentle shaking. The beads were allowed to settle. The supernatant from
each sample was diluted with 600 ul MM and transferred to cell monolayers , 200
ul/well into 4 wells. The viruses were allowed to adsorb and the experiments carried
out as described above.
4.3. Results
4.3.1. Detection of H and Lewis antigens on HEp-2 cells
4.3.1.1. Fluorescence microscopy
Lea was not detected on cell monolayers. A few fluorescent specks were visible on a
minor proportion of cells on monolayers treated with anti-Leb and anti-H2 antibodies.
All cells treated with UEAI, however, were fluorescent.
4.3.1.2. Flow-cytometry
The data from flow cytometry with indirect and direct immunofluorescent techniques
show anti-Leb and anti-H2 at all the dilutions bound to HEp-2 cells but anti-Lea did
not. Fluorescence recorded for HEp-2 cells treated with anti-Leb and anti-H2 at
dilution 1/5 was comparable with that for BEC with these antibodies. Fluorescence
of HEp-2 cells treated with anti-Lea at this dilution was, however, much less
compared with BEC (Fig 4.2). A higher proportion of fluorescent cells with higher













































4.3.2. ELISA for Lewis and H antigens in affinity purified preparations
The amounts of Lea, Leb and H antigens detected by ELISA in the dialysate solutions
of affinity purified antigens for virus inhibition assays were compared with those in
corresponding saliva samples (Table 4.1). The supernatants from the Sepharose beads
were also tested in the ELISA. These solutions contained high concentrations of
antigens and were recycled with the beads to obtain more antigen.
4.3.3. Virus inhibition studies
4.3.3.1. Lewis antigens
Results of 5 assays suggest that RSV was not inhibited by affinity purified Lea or Leb
antigens. In 3 more assays with glycoconjugates containing precursor chain or
precursor chain with Lewis determinants, virus infectivity was not altered.
Incubation of viruses with Synsorb beads linked with synthetic blood group
determinants, Lea, Leb or H, caused about 50% decrease in p.f.u. in all cases
compared with controls (Fig 4.3). The experiment was not repeated because the
beads without any blood group antigens to be used as control were not available from
the manufacturer.
4.3.3.2. Incubation of viruses with H-type 1 antigen
A preparation of purified H-type 1 antigen was obtained from saliva from a Lewis
negative donor but was sufficient for one experiment only. The solution was used in
doubling dilutions in an inhibition assay. Incubation of RSV with the preparation
decreased the number of plaques or syncytia by more than 90% (1st. experiment in
Fig 4.4). A dose related inhibition in virus infectivity was also observed in this








Table 4.1. Amount of Lea, Leb or H-^ in saliva or affinity
purified preparations detected by ELISA. Saliva samples
used for comparison of Lea were from non-secretors and
those for Leb and H]_ were from secretors.
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C Le* Le* H, H, Pre
Treatment
Figure 4.3. Effect of Incubation of RSV with affinity purified Lewis
or H antigens or glyco-oonjugates or Synsorb beads with blood group
activity on plaque formation. (Pre-precursor chain, C-vlrus control)
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Figure 4.4. Effect of Incubation of RSV with affinity-purified H
antigen on plaque formation.
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preparations purified from saliva from the same donor on 3 later occasions (Fig 4.4).
Viruses were also incubated with diluted saliva samples from the donor in one
experiment but no effect on the infectivity was observed.
The inhibitory effects observed in the first experiment might be due to contamination
of the antigen solutions with sodium azide, a constituent of NET buffer or with
molecules of UEAI detached from Sepharose beads during the process of purification
of H antigen. To exclude the latter possibility, the virus suspensions were incubated
with various dilutions of UEAI. UEAI was not toxic to the cells in dilutions ranging
from 1/400 to 1/8000 of the solution used in the purification assays. UEAI did not
cause inhibition of RSV infection of the cells.
4.3.3.3. Incubation of viruses with saliva
Treatment of viruses with boiled saliva from Lewis positive secretors or non-secretors
did not significantly affect the infectivity in 4 experiments (Fig 4.5).
4.3.3.4. Incubation of HEp-2 cells with Lewis and H antigens
The virus particles could not be washed after incubation with the antigens. Controls
were added in each experiment to assess the effects of antigens on cell monolayers
and on the infectivity of RSV. The antigen preparations were not toxic to the cells.
Treatment of monolayers with the preparations did not greatly affect the
RSV-infectivity (Fig 4.6).
4.4. Discussion
Fluorescence was detected more accurately with flow cytometry compared with
microscopy due to the difference in sensitivity between the two methods. Binding of
monoclonal anti-Leb and anti-H2, but not anti-Lea to the cells was detected. Higher
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Treatment with saliva
Figure 44. Effect of Incubation of RSV with saliva samples from
secretors (S) and non-aecretors (NS) on plaque formation. (The




Figure 4.6. Effect of Incubation of HEp-2 cell monolayers with
affinity purified Lewis and H antigens on plaque formation by
RSV.
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proportions of fluorescent cells with higher mean fluorescence were detected with
UEAI compared with anti-H2 antibodies in this study. UEAI detects fucose on both
H-type 1 and H-type 2 and other fucose containing molecules.
The use of plaque assays to study cellular receptors for RSV is limited by a number
of factors. A lysate of RSV-infected HEp-2 cells was used as a source of virus
particles in these experiments. Blood group antigens tested for their inhibitory effect
on virus infectivity were presumably already present in the lysate. RSV cannot be
easily isolated and purified from the lysate because 90% of virus particles remain
associated with the cell membrane [Levine and Hamilton, 1969]. These studies
cannot be conclusive since blood group antigens with the adherent viruses on
glycoproteins might be adsorbed onto the cell surface enhancing infectivity.
The results suggest that affinity purified blood group substances with Lewis or H
blood group activity did not decrease the infectivity of RSV. Lewis and H blood
group antigens bound to HSA added in a proportion of approximately 1014 blood
group determinants per infectious particle of RSV did not reduce the virus infectivity
for HEp-2 cells. The inhibitory effect of a preparation of purified H-type 1 antigens
observed for the first experiment could not be explained but did not appear to be due
to contamination of the preparation with UEAI molecules. The effect was, however,
not reproducible with different preparations of the antigen purified from saliva from
the same donor.
The results from experiments involving incubation of viruses with Synsorb beads
support this conclusion. Beads with H and Lewis determinants uniformly reduced the
number of infective particles, suggesting that the effect was non-specific. This could
most likely be due to physical damage to the virus particles by the beads or due to
trapping of virus particles that are associated with debris of cell membrane in the
bead-bed.
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Assessment of binding of purified blood group determinants with purified G and F
glycoproteins might be a more precise way to analyse the proposed interaction of
blood group antigens with RSV surface antigens.
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Chapter 5
Binding ofNeisseria meningitidis, Haemophilus
influenzae and Staphylococcus aureus to RSV-infected cells
5.1. Introduction
There is extensive evidence that virus infections are prediposing factors for invasive
bacterial disease or carriage of potentially pathogenic bacteria (1.4.8). Most
information has come from studies of influenza virus and bacteria causing pneumonia
such as pneumococci and staphylococci. Infection due to respiratory syncytial virus
(RSV) and meningitis due to N. meningitidis and H. influenzae occur in the same age
groups and during similar periods of the year [Greenwood, 1984; Kim et al„ 1973;
Noah, 1989; Jones and Kaczmarski, 1991; Nazareth et al„ 1992] (Fig 1.2). In the
present study, the effect of viral infection on the initial binding of bacteria to
epithelial cells was investigated.
The HEp-2 cell line was used in assays to determine the effects of RSV infection on
bacterial binding. The HEp-2 cell line is derived from a human laryngeal carcinoma
and consists of non-ciliated epithelial cells. The cells are permissive to RSV and
have also been used for bacterial attachment studies [Stephens, 1989; Layh-Schmitt et
al., 1989]. As the model on which the experiments were based was that of
staphylococcal binding to virus infected cells, a strain of Staph, aureus was also
included in these studies. The bacterial binding was analysed by flow cytometry
(2.7).
In the present study, the hypothesis tested was that HEp-2 cells infected with RSV
might bind meningococci, H. influenzae type b (Hib) and Staph, aureus to a greater
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extent than uninfected cells.
5.2. Materials and Methods
5.2.1. Cells and Virus
HEp-2 cells (Flow Laboratories) between passages 400-420 were used for the
attachment assays. RSV (Edinburgh strain) (a subgroup A strain) [Ogilvie et al.,
1981] was used at the 5th to 7th passages to infect the HEp-2 cells.
5.2.2. Bacteria
A variety of strains of meningococci, Hib (Table 2.1 and 2.2) and a non-toxigenic
(pyrogenic toxins) strain of Staph, aureus (8532) (defined by National Collection of
Type Cultures, NCTC) were used in these assays. Bacteria were cultured as
described in section 2.6. Briefly, meningococci were grown on MNYC medium and
for some experiments on BBA or GC medium while Hib were grown on BBA for all
the experiments. Staph, aureus were cultured on blood agar.
5.2.3. Binding ofmeningococci to HEp-2 cells in monolayers
HEp-2 cells ^.SxlOfyml in GM) were seeded onto glass coverslips (1 ml/well) in 24
well culture plates [Costar] and incubated in 5% C02 in air overnight at 37°C. The
subconfluent monolayers were infected with RSV at different M.O.I, ranging from
0.001 to 1.5 p.f.u./cell. Virus was added in 200 ul of maintenance medium (MM) to
each well for one hour at 37°C. Following adsorption of the virus, the inoculum was
discarded and the infected cells were incubated in MM for 24 hours in 5% C02 at
37°C before they were used in attachment studies with the bacteria.
The bacteria were harvested, washed three times in DPBS by centrifugation at 2500 g
for 15 minutes and resuspended in MM without antibiotics by vigorous pipetting to
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disperse clumps. The bacterial concentration was determined by the optical density
method (section 2.6.2) and adjusted to provide & range of rados of bacteria per cell.
The cell monolayers were washed and incubated at 37°C with 200 ul of the bacterial
suspension for various intervals. The coverslips were washed three times and fixed in
absolute ethyl alcohol for five minutes at rootn temperature. The coverslips were
stained by Gram's stain and examined by light microscopy with an oil immersion
lens. The number of cells counted, number of cells binding bacteria and number of
bacteria per positive cell were recorded. More than 100 cells were counted for each
coverslip. A binding index for each coverslip was obtained by multiplying the
proportion of cells which bound bacteria by wean numbers of bacteria counted.
5.2.4. Binding ofmeningococci to HEp-2 cells in suspension
Overnight monolayer cultures of HEp-2 cells in culture flasks (Costar) (25 cm2) were
infected with RSV at different M.O.I, ranging from 0.001 to 1.0. Viruses (1 ml,
infected cell lysate) were adsorbed for 1 hour and replaced with 10 ml MM. The
cultures were incubated overnight at 37°C.
In one experiment, the cell monolayers were also incubated with inactivated viruses
as above to assess the binding of strain C:2b:P1.2 on mock-infected HEp-2 cells. The
virus suspension (5ml) (lxl06 p.f.u./ml) in a petri dish was exposed to 192 mJ/cm2
of ultraviolet (UV) light. The suspension was tested for inactivation of
viruses by a plaque assay. Cell monolayers in 25 cm2 flasks were incubated with 1
ml/flask of UV-treated suspension. Cultures of mock-treated monolayers were
incubated overnight as above.
Cultures were rinsed twice with DPBS, and ethyienediamine tetra acetic acid (EDTA)
(0.05%) was applied, 1 ml per each flask at 37^*0 for 5-10 minutes to detach the cells
from the surface. MM (5 ml) without antibiotics was then added to the cells to
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terminate EDTA-activity. After centrifugation at 460 g for 7 minutes, the cells were
resuspended in MM without antibiotics, counted and adjusted to lxlQ6/ml. The cell
suspensions were gently rotated at 37°C while the bacteria were prepared. The time
from the end of adsorption of viruses to monolayers to the addition of bacteria was 24
hours (+ lhr).
The bacterial suspensions were labelled with fluorescein isothiocyanate (FITC)
(Sigma) or rhodamine (Eastman Organic Chemicals) as described in section 2.6.4.
The labelled bacteria were washed three times with DPBS and resuspended in MM
without antibiotics. Suspensions of pilate strain were incubated for 2 hours at 37°C in
5% C02 to allow regeneration of bacterial pili.
The concentration of the suspension was determined by the optical density method
(2.6.3) and adjusted to provide a range of ratios of bacteria per cell. The bacterial
suspensions (200 ul) were incubated with equal volumes of suspension of HEp-2 cells
for different periods at 37° C with gentle rotation at 60 rpm in an orbital incubator
(Gallenkamp). At the end of each incubation period, the cells were washed three
times by centrifugation at 460 g for 7 min. The cells were resuspended in 200 ul of
DPBS and fixed with 100 ul of 1% buffered paraformaldehyde (Sigma) [Lanier and
Warner, 1981]. The samples were kept in the dark at 4°C until analysed within 3
days of the assay, mostly on the second day after the experiment.
Each sample was analysed by flow cytometry with an EPICS-C [Coulter Electronic,
Luton, UK]. The results were expressed as binding indices (Bis) calculated for each
sample by multiplying the percentage of fluorescent cells obtained from
Tmmunoanalysis' by the mean fluorescence.
The cells were tested for the proportion of RSV-infected cells in each sample using
immunofluorescent methods described in section 2.5.3.
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5.2.5. Binding of H. influenzae and Staph, aureus to HEp-2 cells
The same method was used to investigate the binding of Hib and staphylococci to
HEp-2 cells infected with RSV at M.O.I. 1.0. Hib were grown on boiled-blood agar
medium for 48 hours. FITC-labelled bacteria were incubated with cells in ratios of
50, 200 and 800 bacteria per cell for 2 hours [St Geme and Folkow, 1990].
Staphylococci were grown on blood agar for 24 hours. The cells were incubated with
FITC-labelled bacteria using 2 ratios of bacteria:cell, 320 and 640, for 30 min at 37°C
[Blackwell et al., in press]. After washing, the cells were analysed in the flow
cytometer as described above.
5.2.6. Statistical methods
The results were analyzed with the statistical package 'Minitab' using multiple
regression on the logarithms of the Bis of the samples. For meningococci, dummy
variables were included to adjust for daily variations in the experiments and different
ratios of viruses and bacteria per cell. The coefficients from this analysis were used
to estimate binding relative to that found for no virus and 10 bacteria per cell by
taking antilogarithms. Examination of the distribution of residuals from the fitted
models suggested that the logarithmic transformation had given an acceptable fit to a
normal distribution. A sign test was used to test for consistency of excess binding of
Hib to RSV-infected HEp-2 cells. A paired t-test was applied to the data from assays
with staphylococci
5.3. Results
5.3.1. Detection of RSV infected cells
The percentage of RSV-infected cells for each M.O.I, was determined by two
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methods, fluorescence microscopy and flow cytometry, The values obtained by the
two methods were comparable, and the proportions of infected cells in the samples
ranged from <10% to >80% at the time of the attachment assay (Table 5.1). No
cytopathic effect was noted at this stage. Random sample of RSV-infected cells did
not show significant change in fluorescence when analysed by flow cytometry on the
second, third or fourth day of the experiment.
5.3.2. Attachment ofmeningococci to cell monolayers
5.3.2.1. Determination of optimum incubation period with monolayers
Binding of meningococci at ratios ranging from 40 to 320 bacteria per cell with the
uninfected monolayers of HEp-2 cells was examined for different incubation periods
(Fig 5.1).
An incubation period of 30 min was used for the following experiments with
meningococci. At this incubation period the binding was at mid-range levels and cells
were not affected. Longer incubation with the bacteria (>1 hour) caused retraction,
rounding and toxic effects on the cells (Fig 5.1.a).
5.3.2.2. Bacterial binding to RSV-infected and uninfected HEp-2 cells in
monolayers: assessed by microscopy
Binding of meningococci to the uninfected and RSV-infected HEp-2 cells at various
ratios of bacteria per cell was examined (Fig 5.2). At ratios of 250-500 bacteria/cell
more bacteria bound to cells in monolayers infected with RSV at M.O.I. 1.5
compared with uninfected cells. At lower M.O.I, the results were equivocal.
Counting by microscopy was, however, subject to errors. Two counts made on some
monolayers gave significant variations (Fig 5.3). As a result the method was
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Table 5.1. Proportion of virus-infected cells in samples
of HEp-2 cells infected with different multiplicity of





























Figure 5.1. Binding of strain C:2b:P1.2 to HEp-2 cells after different









Figure 5.1.a. Replicate monolayers of HEp-2 cells incubated with 250 bacteria
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Figure 5.2. Effect of multiplicity of infection (M.O.I.) of RSV On
binding of strain C:2b:P1.2 to HEp-2 cell monolayers.
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Figure 5.3. Difference between two counts of the same monolayers
of uninfected and RSV-lnfected HEp-2 cells determined by microscopy.
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abandoned.
5.3.3. Attachment of meningococci to cells in suspension assessed by flow cytometry
5.3.3.1. Labelling of bacteria
In one experiment, meningococci were labelled separately with the fluorescent dyes,
rhodamine [Darzynkiewicz et al., 1982] or FITC, to examine their relative brightness
and stability (Fig 5.4). Labelling with FITC was brighter than with rhodamine.
Samples with rhodamine also became non-fluorescent within a week of labelling
while FITC-labelled bacteria were more stable under identical conditions. There
were no significant changes in fluorescence of FITC-labelled bacteria within 3 days
of the experiment For these reasons FITC was chosen to label the bacteria for the
following experiments. Rhodamine-labelled bacteria were used in one experiment at
ratios of 40, 80, 160, 320 and 640 bacteria:cell. Similar to experiments with
FITC-labelled bacteria, HEp-2 cells infected with RSV at M.O.I. 1.0 bound more
bacteria (C:2b:1.2) compared with uninfected HEp-2 cells.
5.3.3.2. Determination of optimum incubation period for attachment of meningococci
to HEp-2 cells in suspension
The FITC-labelled bacteria were incubated with HEp-2 cells in suspension for
various intervals. As with the experiments with monolayers, an incubation period of
30 min was found appropriate for the cells in suspension on the basis of adequate
binding (Fig 5.5) and minimum debris visible on the two-parameter histogram of the
flow cytometer.
5.3.3.3. Effect of media on binding




















Figure 5.4. Fluorescence recorded for meningococci labelled with
fluorescein isothiocyanate (FITC) or rhodamlne.
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Figure 5.5. Binding of strain C:2b:P1.2 to HEp-2 cells after different
Incubation periods determined by flow cytometry.
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RSV infection on binding of meningococci C:2b:P1.2 to HEp-2 cells is illustrated in
Fig 5.6 and 5.7. The left hand peaks correspond to fluorescence recorded with
uninfected cells following incubation with 320 bacteria per cell. The right hand
peaks represent fluorescence observed with the cells infected with M.O.I, of 0.1 (fig
5.6) or 1.0 (Fig 5.7) following incubation with 320 bacteria/cell.
Table 5.2 and Figure 5.8 summarize the results obtained by flow cytometry assays to
assess the effect of viral infection at various M.O.Is. on binding of bacteria. The
results for 11 assays are expressed as estimated percentages of the binding index (BI)
obtained with 10 bacteria per uninfected cell. The results indicate that prior infection
of the cells with RSV at M.O.I, of 0.1 and 1.0 enhanced the binding of
N. meningitidis at ratios of >80 bacteria per cell as illustrated in Fig 5.9
(F(2.51)=37.37, P<0.001).
At lower ratios of bacteria per cell (10-20), the presence of viruses at any level did
not change the binding level significantly; however, the cells infected with an
M.O.I, of 0.001 demonstrated decreased bacterial binding at all ratios compared with
uninfected cells; (F(1.45) = 5.48, P<0.05) (Fig 5.10).
Similar results were obtained with strain C:2b:P1.2 grown on BBA or GC medium
incubated with HEp-2 cells infected with RSV at M.O.I. 1.0 at ratios of 40, 160 and
640 bacteriarcell (Fig 5.11).
5.3.3.4. Effect of mock-infection ofHEp-2 cells on binding of bacteria
The results from the assay using UV-treated viruses show that the incubation of cell
monolayers with suspensions containing one inactivated virus particle/cell did not
significantly alter the binding of bacteria at different ratios of bacteria:cell compared




Binding of FITC labelled N. meningitidis to HEp-2 cells
infected with RSV (MOI 07T) (B) and uninfected cells (A).
Figure 5.7
Log green fluorescence
inding of FITC labelled N. meningitidis to HEp-2 cells
nfected with RSV (MOI 1.0) (B) and uninfected cells (A).
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10* 100 60 69 125 -
20 79 89 123 102 117
40 194 123 125 239 213
80 316 190 323 331 407
160 575 380 467 776 1288
320 1000 588 1148 1905 3311
640 1318 - - 2818 5248
1000 2238 - - 5623 11220
Table 5.2. Effects of infection of HEp-2 cells with RSV
on binding of strain C:2b:P1.2. (* mean for M.O.I. = 0







































No. of bacteria added per cel.
Fig 5.9 Effect of infection of HEp-2 cells with RSV at MOI of
0.1 and 1.0 on binding of Neisseria meningitidis to
the cells.
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Fig 5*10 Effect of infection of HEp-2 cells with RSV at MOI of 0.001
on binding of Neisseria meningitidis to the cells.
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12 r
Figure 5.11. Cumulative binding of strain C:2b:P1.2 grown on NYC,
QC or BBA at 3 ratios of bacteria: cell (text) to HEp-2 cells or HEp-2
cells infected with RSV at M.O.I. 1.0.
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Figure 5.12. Effect of mock-infection of HEp-2 cells on binding of
strain C:2b:P1.2.
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5.3.3.5. Binding of other strains ofN. meningitidis
Results similar to those found with strain C:2b:P1.2 for bacterial ratios 40, 80, 160,
320 and 640 bacteria.cell were obtained with the other strains of meningococci which
expressed different serogroup, serotype and subtype surface antigens. Presence of
pili on the strain Y:14:P1.2 did not affect the binding pattern (Fig 5.13).
5.3.4. Attachment ofH. influenzae to HEp-2 cells in suspension
HEp-2 cells infected with RSV at M.O.I. 1.0 bound significantly more Hib at ratios
50, 200 and 800 bacteria:cell than uninfected cells. Although the effect varied
significantly between experiments, the mean of log differences was positive in all 10
experiments using strain 14 (P<0.01, sign test). Median estimate of binding to
RSV-infected cells as percentage of binding to uninfected cells was 127% (range
104% to 303%). RSV-infection of the cells enhanced bacterial binding at all ratios of
bacteria tested. Although 5 strains of Hib (Table 2.2) differed in antigenic
characteristics, they did not differ in the pattern of increased binding to RSV-infected
cells compared with uninfected cells in 7 repeated assays, nor did the bacteria:cell
ratio affect the binding significantly.
5.3.5. Attachment of Staph, aureus to HEp-2 cells in suspension
Effect of RSV-infection of HEp-2 cells at M.O.I. 1.0 on binding of Staph, aureus
was significant in both ratios of bacteriarcell 320 and 640 (paired t-test); at the ratio
320:cell, t=6.56 (P<0.001) and at 640/cell, t=4.13 (P<0.01). The confidence limits
(95%) for increase in binding due to RSV-infection as % of binding to uninfected
cells were 112, 149 and 114, 161 percent respectively. No significant differences




C:2b:P1.2 NG:-:P1.9 Y:14:P1.2 Y:14:P1.2*
Bactsrlal strains
Figure 5.13. Comparison of cumulative binding of meningococcal
strains to HEp-2 cells and HEp-2 cells infected with RSV at M.O.I.
1.0 at doubling ratios ranging from 40 to 640 bacterla:cell.(* pilate
strain)
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5.3.6. FITC labelling of HEp-2 cells
The possibility that FITC molecules dissociated from FTTC-labelled bacteria and
bound to RSV-infected cells more effectively so that they were more fluorescent
compared with uninfected HEp-2 cells was tested.
HEp-2 cells and the cells infected with RSV at M.O.I. 1.0 were incubated with 2
dilutions (1/4 and 1/8) of the FTTC solution in DPBS for 30 min at 37°C. Fluorescent
cells were detected by flow cytometry. FITC bound to a significant proportion of
cells but at a very low mean fluorescence compared with the mean obtained with
FITC-labelled bacteria. There was also no significant difference in the labelling
detected for uninfected and RSV-infected cells (Fig 5.14).
5.4. DISCUSSION
5.4.1. Method for assessment of bacterial binding
The bacteria responsible for meningitis, (N. meningitidis and H. influenzae, bind to
non-ciliated pharyngeal epithelial cells [Stephens et al., 1983; Read et al., 1991]. Use
of the HEp-2 cell line for study of bacterial binding is relevant as HEp-2 cells are
non-ciliated epithelial cells of human origin. This cell line provides a consistent
source of cells for binding studies.
A variety of strains for each bacterial species with different phenotypes was used in
the assays. Among the viruses affecting the respiratory tract, RSV was chosen
because of the epidemiological coincidence between the diseases caused by the two
types of pathogen .
Microorganisms grown in enriched media might differ in many properties from





Uninfected RSV-lnfeottd Uninfected R8V-lni*cted
FITC solution FITC-labelled bacteria
Figure 5.14. Comparison of fluorescence of uninfected and RSV-infected
HEp-2 ceils Incubated with FITC-solutlon with that of cells Incubated
with FITC-labelled bacteria at a ratio of 80:cell.
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closed system are exposed to a continually changing environment in contrast to the in
vivo environment. Use of systems of bacterial growth in media that provide
conditions which are more like those encountered in the host might be more relevant
to in vivo. In the present binding studies, however, consistent results were obtained
with bacteria grown on different media suggesting that the binding was apparently
not affected by the media used.
Repeated cultures also affect bacterial pili. Pilate strains in general have been shown
to bind more effectively to epithelial tissues compared with non-pilate strain. Pili can
easily penetrate mucus and the epithelial glycocalyx. Pili have been considered to be
responsible for 'initial' attachment to the target tissues and maintenance of a steady
state of bacterial colonization. Once this has occurred in susceptible hosts, non-pilate
progeny might adhere through different adherence mechanisms to obtain a closer
contact with the target tissue leading to invasion. The bacterial strains used in the
present study were non-pilate except for a pilate form of Y:14:P1.2.
Fluorescein isothiocyanate (FITC) was used to label bacteria in this study. FITC
molecules bind to surface proteins non-specifically. The dye did not interfere with
the binding as FTTC-labelled bacteria bound to both HEp-2 cells and RSV-infected
HEp-2 cells. The adhesion was not mediated through FITC as the dye consists of
monomelic molecules. Adhesion to cells by FITC molecules that dissociate from
labelled bacteria during incubation with the cells was not involved in enhanced
fluorescence of RSV-infected cells (Fig 5.14). Similar results showing increased
binding of bacteria to RSV-infected cells were obtained with another fluorescent dye
(rhodamine) used to label bacteria in one experiment (5.3.3.1). The pattern of
increased bacterial binding to RSV-infected cells compared with un-infected cells
was also observed with HEp-2 cell monolayers incubated with un-labelled bacteria.
These observations indicate that FITC was not involved in bacterial binding.
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Airborne droplets from patients with bacterial disease of the size of >10 um that
might be deposited on nasopharyngeal mucosal cells [Mims, 1987] can carry from 20
to many hundreds of bacteria. Ratios used in the assays ranging from 40 to 1000
bacteria/cell are comparable with in vivo conditions. Similar ranges have been
arbitrarily selected for use in bacterial binding studies by other workers [St. Geme
and Falkow, 1990; Blackwell et al. in press].
Meningococci attached more efficiently to RSV-infected cells compared with
uninfected cells as assessed with the monolayer technique. The method was,
however, complicated by the tendency of bacteria to form clumps making counting
difficult. Bacterial counting was further complicated as both cells and bacteria
stained red. The technique was discarded due to variations in the two counts made on
the same samples and limited number of experiments that could be examined. It was,
however, useful for determination of the optimal incubation period before cytotoxic
effects occurred. These effects might be due to release of lipooligosaccharide from
the bacteria [Stephens et al., 1987] or the direct effect of the bound bacteria
[Stephens, 1989].
Measuring fluorescent-labelled bacteria on the surface of cells by flow cytometry is a
more sensitive and precise method than microscopy. More cells can be counted in a
short period of time and there is no subjectivity in the values recorded.
5.4.2. Variations in the technique
There were significant day-to-day variations in the results of binding assays which
can be ascribed to a number of factors.
(1) RSV is characterized by biological and biochemical instability and
pleiomorphism. Amplified production of defective interfering (DI) particles of RSV
by its repeated passages interferes with the standard virus in its infectivity
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(von-Magnus effect). These factors can result in variable infection of cells in the
samples infected at the same M.O.I.
(2) Variable degree of reladve resistance of HEp-2 cells to RSV infection was noted
by fluctuations in the titre of a standard virus preparation [Kim et al., 1973]. Using
immunofluorescence, variations in the expression of F and G glycoproteins on the
surface of infected cells from samples infected at the same M.O.I, were found in the
present study (Fig 5.15). Day to day fluctuations in the binding of bacteria with
aliquots from a stock sample of buccal-epithelial cells have been observed [Tramont,
1977],
(3) Cells at the same growth phase might express different surface antigens. In any
single preparation, the number of bacteria adhering to HEp-2 cells showed great
variations; some cells bound many more bacteria than others. Phasic variations in the
cells have also been demonstrated. Hynes and Bye [1974] noted a very much
enhanced expression of a large glycoprotein on the surface of hamster fibroblasts
arrested in the early growth phase either because of high cell population density or
serum starvation. Although the cells used in the present study were grown and
harvested under uniform conditions, batch to batch variations in the cells might be
another factor reponsible for difference in results of binding experiments.
(4) Measurement of the bacterial concentrations by optical density (OD) can be
variable. The dispersal of clumps in bacterial suspensions can vary which might
affect the OD reading. To examine the variation, counts were determined by light
microscopy and by the optical density method on duplicate suspensions of 5 strains of
H. influenzae used in the assays. The correspondence in readings between the two
methods was not consistent (Tab 5.3). Variations in readings by the OD method were
also indicated when, in some experiments, the counts were checked by
flow-cytometry at a later time (results not shown).
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Figure 5.15. Variation In expression of F and G glycoproteins on
the surface of RSV-lnfected HEp-2 cells assessed by flow
cytometry.
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Table 5.3. Difference between two counts of suspensions
of 5 strains of H. influenzae at optical density (OD)
0.140 determined by light microscopy.
Count X 108/ml







(5) Application of a shear force can reduce the number of bacteria attached to cells.
A 30 fold increase in the force resulted in 70-80% reduction of attached bacteria
[Christersson et al., 1988]. Variation in force used to disperse cells at each washing
could result in detachment of variable proportions of bacteria [Rasanen, 1981].
(6) Detection of particles by the flow cyrometer involves fine adjustments in the
alignment of the laser beam and sample stream with the light sensors. Slight changes
in the settings can affect the results. Changes in the cell suspension or cell flow rate
in the flow cytometer can also affect the results. In all these experiments, the cell
suspensions were kept at a constant starting concentration of lX106/ml. The cells in
suspensions were thoroughly dispersed to avoid clumps. The sample flow in flow
cytometer was also kept at approximately the same rate.
Most of these factors can affect the inter-experimental comparisons of results, a point
to be considered in statistical analysis. Factors such as mechanical shearing which
can cause intra-experimental variations, can be standardized by using uniform
techniques.
5.4.3. Binding to uninfected cells and RSV-infected cells assessed by flow cytometry
In cell samples with <10% infected cells (M.O.I. 0.001), meningococcal binding was
significantly decreased compared with uninfected cells; this was not anticipated.
Internalization of Salmonella typhimurium by HEp-2 cells was inhibited by
pretreatment of cells with tissue necrosis factor (TNF) or TNF and interferon (IFN) a
or y [Degre et al., 1989]. Similarly, treatment of primary chicken kidney cultures
with the INF-y caused inhibition of attachment by sporozoites of Eimeria tenella to
the cells [Kogut and Lange, 1989]. The RSV infected cells might be secreting
soluble factors such as IFN which inhibit binding of meningococci to neighbouring
uninfected cells in the sample. Compared with controls, total bacterial binding was
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not significantly altered for the samples containing 20-30% infected cells
(M.O.I. 0.01). This might reflect the mixed population of infected and uninfected
cells. The effect of enhanced binding to the infected cells might be masked by
decreased binding to the neighbouring uninfected cells mediated by the soluble
factors.
Enhanced binding of meningococci, Hib and staphylococci to cells infected with RSV
at M.O.I. >0.1 24 hr post-infection suggests four possibilities: 1)RSV infection might
be enhancing the expression of existing receptorfs) [Hynes and Bye, 1974]; 2) The F
or G glycoproteins of RSV expressed on the infected cells might act as additional
receptors for the bacteria [Sanford et al., 1978]; 3) It might be inducing expression of
a new cell receptor for the bacteria [Adachi et al., 1988; Okada and Tsuji, 1990]; 4)
RSV infection is associated with appearance of branching filaments on the infected
cells [Parry et al., 1979] which might physically trap the bacteria. Hyoptheses 1 and
2 are tested in chapter 6.
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Chapter 6
Changes in the surface antigens of HEp-2 cells due to
RSV-infection
6,1. Introduction
6.1.1. Blood group antigens and bacterial binding
The evidence that HEp-2 cells infected with RSV bind bacteria more effectively
compared with uninfected cells (Chapter 5) suggests that viruses might (1) enhance
existing bacterial receptor(s) (2) provide additional receptors in the form of viral
glycoproteins (3) induce expression of new receptors and/or (4) help trap bacteria by
physical changes produced on the infected cells.
The higher amounts of Lea antigen on cells of non-secretors has been suggested to
contribute to susceptibility to disease due to H. influenzae, meningococci [Blackwell
et al., 1986a, b], staphylococci [Saadi, submitted for publication] and Candida
species [May et al., 1989; Aly, 1992]. Expression of Lewis and H blood group
antigens on HEp-2 cells was assessed in chapter 4.
The Lewis antigens, the in vivo source of which is largely obscure, are normally
adsorbed on the epithelial surface from the secretions. Viral infections have been
reported to cause changes in the cellular metabolism and surface expression of a
variety of antigens [Hynes and Bye, 1974; Peluso et al., 1978; Caldwell et al., 1988;
Adachi et al., 1988]. HIV has been shown to induce expression of blood groups
antigens on cells normally devoid of these antigens [Arendrup et al., 1991], RSV
infection stimulates glycosylation of macromolecules in HeLa cells [Levine et al.,
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1977] indicating increased enzyme activity. In the first phase of this study, the
hypothesis that higher amounts of Lea, in contrast to Leb or H antigens, might be
expressed on RSV-infected cells compared with uninfected cells was tested.
6.1.2. Viral glycoproteins and bacterial binding
In the second phase, the hypothesis tested was that the F and/or G glycoproteins of
RSV expressed on the surface of infected cells might act as additional receptors for
the bacteria.
6.1.2.1. F and G glycoproteins of RSV
RSV contains a single genome encoding 10 proteins, L (250K), G (84K), F (70K), N
(43K), P (27K), M (28K), M2 (22K), SH (13-30K), IC (15K) and IB (14K). The
seven larger proteins have been reported to be structural and four of them, G,F,M and
24K, are related to the virus envelope [Huang et al., 1985]. Little has been reported
about the structure and function of the M and 24K surface proteins while G and F
glycoproteins are regarded as attachment [Levine et al., 1987] and fusion proteins
respectively [Walsh andHruska, 1983].
The majority of the mature form of the G glycoprotein (85-90K) consists of
monomeric molecules with a 36K polypeptide chain of 298 amino acids [Wertz et al.,
1985; Satake et al., 1985]. A dimeric form of 175K is also found [Lambert, 1988].
The G glycoprotein is secreted by infected cells in a soluble form which is shorter
than the native protein by about 60 amino acids [Hendericks et al., 1987],
The 70K F glycoprotein is composed of two fragments of approximately 50K (Fl)
and 20K (F2) having a polypeptide of 574 amino acids [Collins et al., 1984],
G glycoprotein of RSV is unusual among viral glycoproteins in that it is heavily
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O-glycosylated and has additional potential sites for O-glycosylation [Lambert,
1988]. The glycoprotein does not have neuraminidase or haemagglutination activities
characteristic of the attachment proteins of other members of the Paramyxoviridae
family [Richman et al., 1971]. F glycoprotein of all the members of Paramyxoviridae
is similar in structure and function.
The two glycoproteins are expressed on the surface of RSV-infected cells and can be
detected with specific antibodies.
6.1.3. Objectives
The objectives of this part of the study were:
(1) to compare the effects of pre-treatment of RSV-infected cells with monoclonal
anti-F or anti-G on bacterial binding;
(2) to assess the effect of pre-incubation of RSV-infected cells with bacteria on
binding of anti-F or anti-G;
(3) to demonstrate viral attachment to bacteria and to compare the effect of anti-F and
anti-G on viral attachment of the virus to bacteria.
6.2. Materials and Methods
6.2.1. Effect of RSV-infection of HEp-2 cells on detection of blood group antigens
Fluorescence microscopy and flow cytometry were used to detect the blood group
antigens on HEp-2 cells and HEp-2 cells infected with RSV at M.O.I. 1.0 24 hr post
infection. The methods are described in detail in chapter 4. Some monolayers and
samples of cells in suspensions were assessed in parallel for the presence of RSV.
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6.2.2. Viral antigens and bacterial binding
Different experimental approaches were used to examine the role of viral
glycoprotein in bacterial binding. All the incubations in the experiments were
performed at 37°C with gentle rotation at 60 rpm with an orbital incubator
(Gallenkamp) unless otherwise indicated. FITC-labelled N. meningitidis (C:2b:P1.2)
(2.6.4) grown on BBA and HEp-2 cells and HEp-2 cells infected with RSV at
M.O.I. 1.0 24 hr post-infection were used in these assays.
6.2.2.1. Absorption of antibodies
In some experiments monoclonal antibodies absorbed with HEp-2 cells were used.
The antibodies (200 ul, 1/2 in PBS) were incubated with a pellet of 6X106 cells
overnight at 4°C with gentle end to end rotation. The supernatant was stored in
aliquots at -20°C.
6.2.2.2. Effect of monoclonal anti-F and anti-G antibodies on binding of bacteria to
HEp-2 cells
The method described in section 5.2.4 was used with a few modifications. HEp-2
cells or RSV-infected HEp-2 cells (IX 107/ml MM) (1 ml) were incubated with
un-absorbed or absorbed preparations of monoclonal anti-F or anti-G (1/200) for 30
min. After washing 3 times with DPBS to remove unbound antibodies, the cells were
adjusted at 1 X 106/ml and incubated in 200 ul volumes with equal volumes of
FITC-labelled bacteria at a ratio of 160 bacteriarcell for 30 min. The cells were
washed 3 times, suspended in 200 ul of PBS and fixed with 100 ul of 1% buffered
paraformaldehyde. The samples were analysed by flow cytometry for the percentage
of fluorescent cells and the mean fluorescence.
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6.2.2.3. Effect of bacterial binding on the binding of anti-F or anti-G antibodies to
RSV-infected HEp-2 cells
The cells (200 ul at a concentration of lX106/ml) were mixed with un-labelled
bacteria at a ratio of 2X103 bacteria:cell for 15 min. Longer incubations at this ratio
caused toxicity to cells. After 3 washings with DPBS, the cells with or without bound
bacteria were incubated with monoclonal anti-F or anti-G (un-absorbed) at a dilution
of 1/100 for 30 min. The cells were washed 3 times, suspended in 100 ul PBS and
incubated with FITC-labelled anti-mouse immunoglobulin antibodies (1/200 in PBS)
for 30 min. After 3 washings and fixing, the samples were assessed by flow
cytometry.
6.2.2.4. Determination of viral attachment to bacteria and effect of antibodies on the
attachment
The viral suspensions used in these assays contained 1X106 infectious particles/ml.
The bacterial suspensions were adjusted to lXlOVml. The monoclonal anti-F and
anti-G used in the initial assays were unadsorbed and preparations adsorbed with
HEp-2 cells were used in the latter assays. The combinations of viruses, bacteria and
antibodies examined are illustrated in Table 6.1.
Different incubations carried out are described in the following sections. After
incubations, all the bacterial samples were washed 3 times and mixed with
FITC-labelled anti-mouse immunoglobulin antibodies (Sigma) (2.5.3) (1/200) for 30
min. The samples were washed 3 times and the pellets were resuspended in 100 ul of
DPBS and fixed with 50 ul of 1% paraformaldehyde. The bacteria were analysed by
flow cytometry for the percentage of fluorescent bacteria and the mean fluorescence.
6.2.2.4.1. Incubation of viruses and bacteria with antibodies
Aliquots of viral suspensions or HEp-2 cell lysate (300 ul) were incubated with
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Table 6.1. Incubations of bacteria with RSV (RSV-infecteci
cell lysate), HEp-2 cell lysate, monoclonal anti-F or
anti-G and anti-mouse immunoglobulin antibodies during
assays of virus attachment to bacteria and inhibition of
attachment.




- + - - - +
Virus or
cell lysate




- - - - + -
Anti-F or
anti-G




- + + + + +
+ = added
- = not added
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different dilutions of monoclonal anti-F or anti-G for 60 min. Bacterial suspensions
(300 ul) (1 X 108/ml) were similarly incubated with the antibodies for 30 min and
washed 3 times with DPBS by centrifugation at 2500 g for 10 min. The bacterial
suspensions were adjusted at 1 X lOVml. The antibody-treated preparations of viruses
or bacteria were used in the latter part of the experiment.
6.2.2.4.2. Virus attachment to bacteria
Samples (30 ul) of bacterial suspensions or bacterial suspensions treated with either
of the antibodies (6.2.2.4.1) were mixed with 300 ul of cell lysate or virus suspension
to provide a ratio of 100 infectious particles (p.f.u.)/bacterium for 30 min. After
washing 3 times, the bacterial preparations were incubated with anti-F or anti-G at a
dilution of 1/100 for 30 min.
6.2.2.4.3. Inhibition of viral attachment
To examine the blocking effect of the two antibodies, the bacteria (IX lOVml MM)
(30 ul) were incubated for 30 min with 300 ul of cell lysate or virus suspension (100
p.f.u./bacterium) that had been treated with either of the two antibodies at different
dilutions (6.2.2.4.1).
6.2.2.5. Statistical methods
No formal statistical analysis could be performed on the data from the assays
examining the role of antibodies for experiments outlined in section 6.2.2.2 and
6.2.2.4 because too few replicate experiments were done. The number of experiments
were limited by the small supply of monoclonal anti-F and anti-G antibodies. A
paired Y test was done on logs of binding indices obtained from each sample in
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experiments examining the effect of bacterial binding on binding of anti-F or anti-G.
6.3. Results
6.3.1. Effect of RSV-infection of HEp-2 cells on detection of blood group antigens
6.3.1.1. Fluorescence microscopy
The monolayers infected with RSV (M.O.I. 1.0) 24 hr post-infection showed about
80% fluorescent cells when tested with monoclonal antibody to F glycoprotein of
RSV. RSV infection did not change the patterns of binding of monoclonal antibodies
to Lea, Leb, H-type 2 or FITC-UEAI on HEp-2 cells (4.3.1.1).
6.3.1.2. Flow-cytometry
The data from 4 experiments assessed by flow cytometry using indirect
immunofluorescent techniques suggested that RSV infection of the cells did not
change the binding of antibodies or UEAI to HEp-2 cells (Fig 6.1). Fluorescence on
cells with anti-Lea could only be expressed as percentage of fluorescent cells as
means for small percentages cannot be obtained.
6.3.2. Viral antigens and bacterial binding
6.3.2.1. Effect of monoclonal anti-F and anti-G antibodies on binding of bacteria to
HEp-2 cells
Results from 5 replicate experiments indicate that pre-treatment of both uninfected
and RSV-infected cells with monoclonal anti-F or anti-G (both at 1/100) reduced the












































Figure 6.1. Effect of RSV-infection of HEp-2 ceils on binding of
monoclonal antibodies to Lewis and H-type 2 antigens and FITC-
labelled UEAI. An indirect immunofluorescence technique was
used for antibody assay.
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compared with uninfected cells was not altered (Fig 6.2). The antibody preparations
were adsorbed with HEp-2 cells in an attempt to reduce non-specific effects. Results
from 4 repeated experiments with adsorbed preparations (1/100) indicate that anti-F
did not affect binding to uninfected HEp-2 cells, but anti-G increased the binding to
these cells. The reasons for this increase could not be explained; but antibody
molecules were not likely to be involved since the antibodies could not be detected on
uninfected cells by flow cytometry. Both the antibodies decreased bacterial binding
to RSV-infected cells but the effect appeared to be more pronounced with anti-G (Fig
6.2).
6.3.2.2. Effect of bacterial binding on binding of anti-F and anti-G to RSV-infected
HEp-2 cells
Results from 7 experiments indicate that both the antibodies bound to the viral
glycoproteins on the surface of infected cells, but the mean fluorescence recorded on
the cells incubated with anti-G was higher compared with anti-F (P<0.05).
Significantly lower levels of mean fluorescence were recorded for anti-G with
RSV-infected cells pre-treated with bacteria compared with the infected cells that had
not been treated with bacteria (P<0.01). This effect was not observed with anti-F (Fig
6.3). Amounts of fluorescence detected on cells in the experiments with anti-G
corresponded to a dose-response effect with ratios of bacteriarcell ranging from 500 to
4000 (Fig 6.4).
6.3.2.3. Viral attachment to bacteria and the role of antibodies in inhibition of the
attachment
RSV attached to meningococci in 12 repeated assays. Both the antibodies, in
unabsorbed state, incubated with viruses at a dilution of 1/100 increased attachment
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No antibody B8888888S Antl-F imrnrMi Anti-a
Figure 6.2. Effect of incubation of HEp-2 cells and RSV-infected
HEp-2 cell with different preparations of monoclonal anti-F or
anti-Q antibodies on binding of fiuorescein-labelled meningococci.
Uninfected RSV-infected
Incubation with adsorbed antibody
Uninfected RSV-infected
Incubation with un-adsorbed antibodies
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■ Antl-F ■ Ant!—G
Figure 6.4. Dose-response
effect of incubation of RSV
infected HEp-2 ceils with
bacteria on detection of F
and G glycoproteins.




Figure 6.3. Average effect of incubation of RSV-infected HEp-2 cells
with meningococci at a ratio of 2X103 bacteria:cell on detection of
F and G glycoproteins observed in 7 replicate experiments.
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of the viruses to bacteria in 4 experiments. Results from 4 assays using adsorbed
preparations at dilution 1/200 showed that anti-F did not alter the viral attachment to
the bacterium while anti-G reduced the attachment greatly (Fig 6.5). The adsorbed
antibodies used at dilution 1/100 gave variable results (not shown).
The antibodies incubated with bacteria had variable effects on subsequent viral
attachment; monoclonal anti-F reduced the viral attachment while anti-G increased it.
The non-specific effect of antibody preparations on viral attachment was partially
reduced by absorption of the antibody preparations with HEp-2 cells and by the use
ofmore diluted preparations of antibodies (1/200). When incubated with bacteria, the
adsorbed preparation of anti-F still reduced the subsequent viral attachment while
anti-G did not greatly affect the attachment (Fig 6.6).
6.4. Discussion
RSV infection did not change the binding of UEAI or monoclonal antibodies to Lea,
Leb or H-type 2 antigens on the cells. The hypothesis that enhanced expression of
Lea antigen might be associated with increased binding of the bacteria on
RSV-infected FLEp-2 cells was disproved.
Antibodies to viral glycoproteins have been used in studies of inhibition of bacterial
binding to receptors on virus-infected cells [Sanford et al„ 1978]. Use ofmonoclonal
antibodies in these assays is limited as they might not be directed to an epitope of the
molecule interacting with bacterial adhesins. Preparations of polyclonal antibodies or
a combination of monoclonal antibodies directed to different epitopes on the
proposed receptor molecule might be more useful in studies to identify a receptor.
The results of the assays in which bacterial binding was assessed after the cells were
treated with anti-F or anti-G were difficult to interpret because the treatment
enhanced the bacterial binding to uninfected HEp-2 cells. These effects could be due
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No antibody . Unabsorbed Absorbed
1/100 1/200
Figure 6.5. Effect of Incubation of RSV with different preparations
of monoclonal antl-F or antl-Q antibodies on virus attachment to
meningococci (12 experiments).
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HSiMl Unadtorbed No antibody llllllllllllllll Adsorbed
400 r
x
No . Anti-F Antl-G
Treatment
Figure 6.6. Effect of incubation of bacteria with unadsorbed or adsorbed
anti-F or antl-G antibodies on attachment of RSV to bacteria
(8 experiments).
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to substances other than antibodies present in the ascitic fluid. The non-specific
effects were partially removed by adsorption of the preparations with HEp-2 cells.
The antibodies could not be purified by immunoaffinity because the purified F and G
glycoproteins were not available.
There was some evidence that anti-G inhibited bacterial binding to RSV-infected
cells (Fig 6.2). On the other hand, the presence of bacteria on the cell surface
significantly reduced the binding of anti-G (Fig 6.3). It is not clear if the decrease in
binding of anti-G was due to binding of bacteria to the epitope specific for the
antibody idiotype or due to steric hindrance.
The evidence of viral attachment to the bacteria also suggests that viral surface
proteins might be involved in bacterial binding. The attachment of viruses to bacteria
could be reduced by the adsorbed preparation of anti-G but not by anti-F antibodies.
The increased attachment of viruses with higher concentrations of antibodies in some
experiments might be due to attachment of large aggregates of viruses in
antigen-antibody complexes. This could also be due to non-specific effect on bacteria
due to substances present in the antibody preparations such as products of
inflammatory activity in the ascitic fluid used as the source of antibodies. The
non-specific effect could not be completely removed by adsorption with HEp-2 cells.
Adsoiption with bacteria would be preferable but it was not possible because of
limited amount of the monoclonal anti-F and anti-G antibodies.
In conclusion, the results presented here indicate that the surface glycoprotein G
contributes to the increased adhesion ofmeningococci to RSV-infected HEp-2 cells.
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Chapter 7
Effect ofmodification of cell surface carbohydrates on
bacterial binding to HEp-2 cells
7.1. Introduction
Many receptors for bacteria on host epithelial surfaces are carbohydrates. Adhesins
of Vibrio cholerae appeared to bind to D-mannosyl and L-fucose receptors [Jones and
Freter, 1976]. Work of Ofek and Beachey [1978] and Leffler and Swanborg-Eden
[1980] revealed sugars, galactoside and D-mannosyl, involved in binding of E. coli.
Sialic acid moieties on sheep erythrocytes were identified as receptors for
Mycoplasma pneumoniae [Feldner et al., 1979]. Attachment of a variety of
Gram-positive and Gram-negative organisms to mouse peritoneal-exudate
macrophages was inhibited by glucose and galactose [Freimer et al., 1978].
Monosaccharides, N-acetyl-D-galactosamine, D-galactose, a-methyl-D-mannoside
and L-fucose, inhibited the binding of E. coli, Bacillus subtilis and Bacillus melitensis
to lymphocytes. Conversely, the binding of Staph, aureus to these cells was
increased in the presence of N-acetyl-D-galactosamine [Rasanen, 1981].
H. influenzae, N. meningitidis and Staph aureus were found not to possess
mannose-binding activity [Mirelman et al. 1980]. The effects of other
monosaccharides were not included in their study.
7.1.1. Chemical nature of G and F glycoproteins of RSV
G glycoprotein of RSV consists of 50-60% sugars. The polypeptide contains 298
amino acids over 30% of which are hydroxy-amino acids, serine and threonine
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[Wertz el al., 1985; Grubber and Levine, 1985]. These amino acids provide sites for
O-glycosylation. About half of the sites must be glycosylated for maturation of the
molecule; the rest remain unoccupied [Lambert, 1988]. The N-terminus of the
protein is intracellular. The peptide from 64-298 amino acids is predicted to be
extracellular and 77 out of 91 potential sites for O-glycosylation are clustered in this
region. The glycoprotein contains a high proportion of basic amino acids [Satake et
al., 1985] and proline residues making it a mucinous type of protein [Wertz et al.,
1985]. Seven asparagine residues which are potential sites for attachment of sugars
through N-linkage reside near the C-terminal [Lambert, 1988].
F glycoprotein has 5 potential acceptor sites for asparagine-linked sugars
(N-glycosylation) and a site for proteolytic cleavage of the molecule into F1 and F2
fragments. Carbohydrates of the molecule are completely sensitive to tunicamycin,
an antibiotic which inhibits N-glycosylation. Carbohydrates, mainly located in the
F-2 segment, make up 13% of its mass [Lambert, 1988].
7.1.2. Reagents used to modify carbohydrates
A variety of reagents have been employed to delete chemical groups from the surface
molecules in an attempt to discover the role of these groups in bacterial binding.
These include enzymes and chemicals which specifically cleave defined groupings or
inhibit addition of groups to molecules.
7.1.2.1. Monensin
Monensin is a carboxylic ionophore that interferes with the membrane flow of
proteins between the medial and the trans compartment of the Golgi apparatus. This
blockage results in inhibition of O-glycosylation and of trimming of some other
sugars bound to proteins, but N-glycosylation is not affected [Pressman, 1976],
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Monensin treatment does not affect the transportation of the F and G glycoproteins to
the surface of infected HEp-2 cells [Satake etal., 1985].
With monensin and related enzymes, G glycoprotein has been shown to be
glycosylated through both O- and N-linkages. Tunicamycin causes a slight decrease
in size of the molecule. In comparison, monensin treatment results in a dramatic loss
of molecular weight [Wertz et al., 1985] indicating that the molecule is mainly
O-glycosylated. Monensin also significantly reduces the yield of the infectious virus
particles. Yield of RSV from HeLa cells was inhibited by 99.6% when the infected
cells were treated with monensin (0.1 uM) 2 hr post-infection [Gruber, 1985].
7.1.2.2. Periodate
Sodium periodate (NaI04) cleaves C-C bonds and oxidizes alcohol groups to
aldehydes on terminal sugars of molecules. Mild treatment with periodate has been
shown to remove the terminal two carbon atoms from sialic acid while it causes
minimal destruction to other sugars within molecules. Severe treatment can cause
destruction of additional neutral sugar residues within oligosaccharide chains [Lenten
and Ashwell, 1971]. For instance, treatment of glycopeptides obtained from human
y-globulin with 0.06 M periodate (severe treatment) resulted in total loss of sialic
acid, fucose and galactose and partial loss of glucosamine moieties. This treatment
also causes partial oxidation of amino acids such as tyrosine, tryptophan, cystine and
methionine. In the glycopeptides from human y-globulin, 56% of tyrosine was lost
during the procedure [Rothfus and Smith, 1963].
The objective of this part of the study was to determine if the surface carbohydrate
moieties of G glycoprotein were involved in the increased bacterial binding to
RSV-infected HEp-2 cells.
138
7.2. Materials and Methods
All the incubations were carried out at 37°C with rotation at 60 rpm in an orbital
incubator (Gallenkamp) unless otherwise indicated. DPBS was used for washing
during the experiments. Meningococcal strain C:2b:P1.2 grown on BBA and HEp-2
cells and HEp-2 cells infected with RSV at M.O.I. 1.0 were used for the binding
studies.
7.2.1. Treatment of cells with reagents
7.2.1.1. Treatment of cells with monensin
A stock solution containing 10 mM monensin (sodium salt) (Sigma) was prepared in
absolute ethyl alcohol and stored in aliquots at -70°C for use within 3 months of
preparation. For determination of toxic effects and effects on RSV infection of the
cells, HEp-2 cell monolayers in 25 cm2 tissue culture flasks were grown in medium
containing monensin at 0.1 uM. Monensin-treated or untreated monolayers were
infected with 200 infectious virus particles in 2 ml MM. After adsorption for 60 min,
the monolayers were washed twice and kept in MM for 2 hr. The monolayers were
maintained in overlay medium (without additional NaHC03) (2.5.2.1) with or without
monensin for 3-4 days until cytopathic effects appeared.
The cells for bacterial binding assays were treated with monensin as follows.
Monolayers of HEp-2 cells or RSV-infected HEp-2 cells 2 hr post-infection were
incubated with monensin at concentrations ranging from 0.05 uM to 0.2 uM in MM
[Gruber and Levine, 1985; Satake et al., 1985]. The cells were harvested with EDTA
18-20 or 30 hr post-infection as described in section 5.2.4. The cell count was
adjusted to lX106/ml in MM without antibiotics.
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7.2.1.2. Treatment of cells with sodium periodate
Aliquots of stock solution containing sodium m-periodate (NaI04) (Sigma) at 150 uM
in distilled water were stored at 4°C. Samples of suspensions of HEp-2 cells and
RSV-infected HEp-2 cells 20 hr post-infection were incubated with sodium periodate
at concentration of 1 uM (mild treatment) or 7.5 uM (severe treatment) [Ofek et al„
1977; Ogmundsdottir et al„ 1978] in MM without antibiotics for 5 or 20 min. After
washing 3 times, the count was adjusted to lX106/ml in MM without antibiotics.
7.2.1.3. Treatment of cells with neuraminidase
One unit of neuraminidase (Sigma) releases up to 1.0 mM of N-acetyl neuraminic
acid per minute (manufacturer's information). Aliquots of suspensions (300 ul)
containing 3X105 uninfected or RSV-infected HEp-2 cells were incubated with 0.1
units of neuraminidase at pH 6.0 for 20 min. The cells were washed and counted as
described above.
7.2.2. Bacterial binding assays
Following the treatments described above, cells were used in binding assays with
different ratios of bacteria:cell as described in section 5.2.4. Binding of
fluorescein-labelled bacteria to the cells was analysed by flow cytometry as described
in section 2.7.
7.2.3. Detection of viral glycoproteins on the infected cells
In parallel with the bacterial binding assays, the treated RSV-infected cells were
compared with untreated RSV-infected cells for interaction with monoclonal anti-G
(2.5.3.2). Monensin-treated infected cells were also assessed for effects of treatment
on F glycoprotein. The effects of other treatments on F glycoprotein could not be
examined due to limited supply of the monoclonal anti-F.
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7.2.4. Statistical methods
The data from repeated binding experiments using cells treated with monensin (7
experiments) or periodate (7 experiments) were subjected to 'analysis of variance'
carried out on logs of binding indices. The paired t-test was used to analyse the effect
of the monensin or periodate on the detection of G glycoprotein. The results from
binding studies in which neuraminidase was examined were not formally analysed
due to small number of experiments (2 experiments).
7.3. Results
7.3.1. Effect of RSV-infection on bacterial binding
The overall effect of increased binding of bacteria at a range of ratios (80 to 1280)
bacteriarcell to RSV-infected cells compared with uninfected cells was significant
(PcO.OOl). This confirmed the finding from earlier binding studies (Chapter 5).
7.3.2. Results from monensin treated cells
7.3.2.1. Effect of monensin on cell morphology and RSV infection
HEp-2 cells incubated with 0.1 uM of monensin for 4 days were of unusual spindle
shape with branching processes. Treatment of cells with monensin for 24 hr,
however, caused only minimal histological changes but it slowed down the cell
replication (Fig 7.1). Monensin greatly reduced the permissibility of HEp-2 cells to
RSV infection; but, after the cells were successfully infected with the virus, treatment
with monensin did not greatly affect plaque formation (Fig 7.2).
7.3.2.2. Effect of monensin on bacterial binding and detection of viral glycoproteins
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Figure 7.1. Replicate monolayers of HEp-2 cells maintained in maintenance




Figure 7.2. Effect of monensln on formation of plaques In HEp-2 cell
monolayers by infectious particles of RSV. (M - incubation of
monolayers with monensln during pre-lnfectlon period and
m - during post-Infection period).
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with monensin (0.1 uM) for 20 hr. The values shown are estimated percentages of
the average value of binding indices obtained with untreated, uninfected cells. The
results indicate that at 0.1 uM monensin, binding of bacteria to both uninfected and
RSV-infected HEp-2 cells was increased at ratios, 80, 160, 320, 640 and 1280
bacteriaxell; however, the increase was not statistically significant. The effect was
not significant for individual ratios tested.
Results from samples incubated with monensin at 0.05 and 0.2 uM for 20 hr did not
differ from those obtained with monensin at 0.1 uM (Fig 7.4). Longer incubation with
monensin (30 hr) at 0.1 uM, however, increased the binding greatly to both
un-infected and RSV-infected cells. It did not, however, alter the pattern of increased
binding to RSV-infected cells compared with uninfected cells (Fig 7.5).
7.3.2.3. Effect of monensin on detection of viral glycoproteins on surface of infected
cells: assessed by flow cytometry
Data from immunofluorescence assays with flow cytometry for detection of F and G
glycoproteins on the surface of infected cells show that incubation with monensin at
0.1 uM for 20 hr reduced the detection of G glycoprotein significantly (P<0.05),
whereas this treatment did not affect F glycoprotein. The effect on G glycoprotein
was proportional to the dose of monensin used. The longer incubation (30 hr) with
monensin at 0.1 uM resulted in decreased detection of both the antigens, but G
glycoprotein was more affected (Fig 7.6).
7.3.3. Effect of periodate on bacterial binding and detection of viral glycoproteins
7.3.3.1. Effect on bacterial binding
Analysis of data from 7 experiments with uninfected and RSV-infected HEp-2 cells
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Uninfected RSV-lnfected
Figure 7.3. Effect of monensln (0.1 uM) on binding of meningococci
to uninfected and RSV-lnfected HEp-2 cells in 7 experiments.
(M - monen8in treatment)
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Uninfected RSV-lnfected
Figure 7.4. Binding of meningococci to uninfected and RSV-infected




Figure 7.5. Binding of meningococci to uninfected and RSV-lnfected
HEp-2 cells incubated with monensin (0.1 uM) for different periods.
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Figure 7.6. Detection of F and G glycoproteins following treatment
of RSV-lnfected HEp-2 cells with various dilutions of monensln for
different Incubation periods.
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treated with periodate for 5 min indicates that at 1.0 uM, periodate did not affect the
bacterial binding significantly at ratios of 100, 200 and 400 bacteriarcell. Both
uninfected and RSV-infected cells treated with periodate at 7.5 uM bound more
bacteria compared with untreated cells at all ratios of bacteriarcell (P<0.001).
Periodate treatment did not alter the statistically significant increase in bacterial
binding to RSV-infected cells compared with uninfected cells (Fig 7.7). Longer
incubation (20 min) of the cells with periodate at 1.0 uM resulted in a similar pattern
of increased bacterial binding to both uninfected and RSV-infected cells (Fig 7.8).
7.3.3.2. Effect of periodate on detection of G glycoprotein on RSV-infected cells
At 1.0 uM periodate resulted in a small decrease in the detection of G glycoprotein.
The effect was greater with periodate at 7.5 uM (Fig 7.9).
7.3.4. The effect of neuraminidase on bacterial binding and detection of viral
glycoproteins
Data from two experiments with HEp-2 cells incubated with neuramindase indicate
that the enzyme increased bacterial binding to both uninfected and RSV-infected
HEp-2 cells at ratios of 100, 200 and 400 bacteriarcell (Fig 7.10). There was a slight
reduction in detection of G glycoprotein on RSV-infected cells that were treated by
the enzyme (Fig 7.9).
7.4. Discussion
Because carbohydrate antigens on epithelial surfaces often act as receptor for
bacterial adhesins, the present studies were carried out to determine if carbohydrate








Figure 7.7. Binding of meningococci following treatment of uninfected
and RSV-infected HEp-2 cells with periodate at different concentrations.
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Figure 7.8. Binding of meningococci following perlodate (1 uM)
treatment of uninfected and RSV-lnfected HEp-2 ceils for different
Incubation periods.
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Figure 7.9. Detection of Q glycoprotein on RSV-lnfected cells




Figure 7.10. Binding of meningococci following treatment of uninfected
and RSV-infected HEp-2 cells with neuraminidase in 2 experiments.
(R - RSV-infection, N - neuraminidase treatment)
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Loss of O-linked sugars of glycoproteins caused by monensin resulted in a decrease
in detection of anti-G-defined epitopes. This could be due to monoclonal anti-G that
might recognize sugars moieties on G glycoprotein or decreased mean levels of
expression of G glycoprotein in the absence of O-glycosylation compared with that
observed under conditions of full sugar addition [Wertz, 1989]. The detection of
anti-F-defined epitope was not affected. F glycoprotein is involved in formation of
syncytia in RSV-infected cell monolayers. The lack of effect of monensin on F
glycoprotein was also shown by an un-altered formation of syncytia in monolayers
that were treated with monensin during the post-infection period.
Removal of sialic acid and some internally placed neutral sugars from the molecules
and oxidation of small numbers of aminoacids by treatment of cells with high
concentration (7.5%) of periodate reduced the binding of the anti-G monoclonal
antibody. Removal of sialic acid with neuraminidase had similar effects.
Conversely, removal of the terminal two sugars from sialic acid following mild
treatment of cells with periodate did not affect the detection of G glycoprotein. Loss
of O-linked sugars or sialic acid of the G glycoprotein with resultant decrease in
detection of anti-G-defined epitope suggest that the monoclonal anti-G was partially
directed to sugars in the molecule.
These reagents caused changes in bacterial binding to both un-infected and
RSV-infected HEp-2 cells. Whereas loss of O-glycosylation due to monensin
treatment of uninfected and RSV-infected HEp-2 cells for 20 hr increased the binding
but not significantly, the binding was significantly increased following longer
treatment periods (30 hr). Biochemical effects of longer treatment are not
documented, but could result from disruption of molecules causing gross changes in
the cell morphology (Fig 7.1). Removal of sialic acids and possibly some internal
sugars from the molecules and oxidation of some amino acids due to periodate
(severe treatment) also increased binding to uninfected and RSV-infected cells.
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The results suggest that the carbohydrate moieties affected by treatment with
monensin, periodate or neuraminidase are not involved in enhanced binding of
meningococci observed with RSV-infected cells. These findings suggest that protein
moieties are involved in bacterial binding. Sugars attached to these epitopes might
cause steric hindrance to binding. Since the enhancing effect of removal of sugars on
the binding was observed with both uninfected and RSV-infected cells, it is not clear
whether the effect was attributed to changes in receptor(s) native to cells alone. The
proportional increase in binding to uninfected cells due to treatment was not greatly
different from that in infected cells. It is, however, likely that protein moieties of the
G glycoprotein were involved in binding since exclusion of sugars from the G
glycoprotein did not cancel the enhancing effect of viral infection on bacterial
binding.
The yield of infectious RSV particles from monensin treated cells is severely reduced
[Satake et al., 1985] suggesting O-glycosylation is important in production of
infectious particles. The absence of O-linked sugars might affect the configuration
and maturation of G glycoprotein [Wertz et al., 1989]. The role of sugars of the G
glycoprotein in the attachment of RSV to epithelial cells was, however, not
questioned in these studies. In the present study, monensin-treated HEp-2 cells,
devoid of O-linked sugars, were not permissive to RSV suggesting that virus-cell
association was dependent on O-linked carbohydrates present on the surface of
HEp-2 cells. In that case, carbohydrate moieties of G glycoprotein might not directly
take part in its attachment function.
In conclusion, these results suggest that protein moieties of G glycoprotein of RSV




Results of the experiments have been discussed in detail in previous chapters. This
chapter summarizes the conclusions with reference to the validity of experimental
methods and suggests further studies.
8.1. Secretor status, bacterial meningitis and viral infections
Non-secretion of ABO blood group antigens has been reported to be one of the host
factors associated with bacterial meningitis. One objective of the study was to test
the hypothesis that non-secretors might be more susceptible to respiratory viral
infection. The hypothesis was based on epidemiological evidence that viral
infections might be predisposing factors for meningitis or carriage of bacteria
associated with meningitis. In contrast to the prediction, secretors were
over-represented among the hospitalized patients with disease due to respiratory
viruses. The role of Leb and/or H-type 1 antigens present on cells of secretors as
receptors for RSV was examined. Molecules with Leb or H type 1 determinants did
not inhibit RSV-infection ofHEp-2 cells.
8.2. Binding of bacteria to virus-infected cells
Bacterial binding to mucosal cells is an initial step in the pathogenesis of invasive
disease. The second objective was to assess the effect of RSV-infection of HEp-2
cells on binding of bacteria responsible for meningitis. RSV-infected HEp-2 cells
bound significantly more bacteria than uninfected cells. The increased binding was
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not associated with a change in the expression of Lewis or H blood group antigens on
RSV-infected cells.
8.2.1. A criticism of binding studies
Bacterial association with host mucosal surfaces is affected by a large number of
factors. Components of the lining mucus gel, substrates for bacterial growth or
dietary lectins can competitively bind to bacterial adhesins and modify binding to
specific receptors on cells. The presence of endogenous microflora on the mucosa,
local antibodies or adherence of invading pathogens to secreted molecules (e.g.,
blood group antigens or fibronectin) can also affect bacterial binding to mucosal cells.
Although association with the mucosa is often important for bacteria for colonization
or disease, this could also result in effective elimination by the host by shedding of
mucosal cells. A single in vitro binding assay analysing an adhesin-receptor
interaction dissociated from the other relevant in vivo conditions is of limited value
for determining correlations between bacterial adhesion and pathogenicity.
Alternatively the interdependence of individual host and virulence factors can be
reproduced in animal models. Animal models could, however, be equally criticised if
used to examine human pathogens such as bacteria causing meninigits.
Another objection to in vitro models for binding studies is that bacteria often possess
more than one surface component for binding to cells. Binding assays would,
nevertheless, be valid for determination of some of the various adhesive mechanisms
that a given bacterium can exhibit. A correlation between in vitro adherence and in
vivo infectivity has been shown for a variety of bacterial pathogens [reviewed by
Beachey, 1981]. The model used in the present studies is relevant to in vivo
infections; the viral glycoproteins expressed on RSV-infected HEp-2 cells are also
expressed on epithelial cells of virus-infected mucosa.
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The effects of subculturing on bacterial phenotype and FITC-labelling of bacteria on
binding to cells has been discussed in chapter 5.
8.2.2. Role of viral glycoproteins in bacterial binding
The experimental approach for determination of cell receptors for bacteria should
ideally involve inhibition of binding by specific antibodies or by receptor analogues.
Use of mutant cells and bacterial strains deficient in the proposed interacting ligands
are a complementary approach. Enzymatic or chemical modification of cells or
bacteria help to determine the chemical group of the molecule important in binding.
Results from the assays with antibodies to viral surface glycoproteins suggested that
F glycoprotein was not associated with enhanced bacterial binding and that G
glycoprotein might be a candidate. Viral glycoproteins could not be used in binding
inhibition studies since the glycoproteins in purified form were not available. The
use of G and F glycoproteins in these assays might also be complicated due to
interaction of these glycoproteins with HEp-2 cells. The surface of the RSV particles
is characterized by the presence of the two glycoproteins. The successful attachment
of the virus particles to bacteria (Chapter 6) suggested viral glycoproteins might be
receptors for bacteria.
Lectins with sugar binding activity have been demonstrated in human epithelial
tissues [Sparrow et al„ 1987]. Although carbohydrates usually act as cell surface
receptors for bacteria, the evidence presented in chapter 7 from experiments with
enzyme- or chemically treated cells suggested that protein moieties are involved in
binding of meningococci to HEp-2 cells or RSV-infected HEp-2 cells.
Monoclonal anti-G and meningococci competed for the receptor on RSV-infected
HEp-2 cells but did not completely inhibit each other (Chapter 6). Anti-G attached to
an epitope which appeared to consist of both sugar and protein since loss of sugars
/
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from G glycoprotein resulted in reduced detection by anti-G but did not abolish it
(Chapter 7).
Meningococci possess N-acetyllactosamine structures in their lipooligosaccharide
(LOS) antigens which have been proposed as adhesins for binding to cellular lectins
[Mandrell et al., 1988]. The evidence that meningococci treated with mannose
agglutinated yeasts [Mirelman etal.. 1980] supports this finding.
Hydrophobicity is one of the important attractive forces in bacterial binding. G
glycoprotein of RSV is not overtly hydrophobic. A region of maximum
hydrophobicity lies between 41 and 63 residues from the N-terminus and is
considered the best candidate for membrane anchoring [Wertz et al., 1985]. Another
smaller, conserved, hydrophobic segment exists from residues 164 to 176. This
epitope might be the attachment site of the virus [Johnson et al., 1987]. It is devoid
of any site for N- or O-glycosylation [Wertz et al., 1985]. The virus is unable to
infect HEp-2 cells that have lost O-linked sugars due to treatment with monensin
(Chapter 7). This suggests that viral structures interacting with carbohydrate receptor
epitope(s) are protein in nature.
The hydrophobic nature of the attachment domain between 164 to 176 might reduce
its accessibility to antibodies. Monoclonal antibodies to G glycoprotein partially
neutralized the infectivity of RSV [Anderson et al., 1989]. The incomplete inhibition
of bacterial binding by monoclonal anti-G (Chapter 6) might be due to relative
inability of antibodies to interact with the hydrophobic epitope on the G glycoprotein.
There are many potential sites for O-glycosylation on the G glycoprotein. These sites
might be inaccessible to enzymes. A number of bacteria recognize lactosylceramide
(a bilayer-close lipid-bound epitope) which is not normally accessible for galactose
oxidase [Bock et al., 1988]. It is proposed that bacteria might prove better than single
molecules of enzymes to reach an internalized epitope by inducing lateral diffusion of
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surface components that arc masking the epitope. Bacterial enzymes such as protease
of pathogenic meningococci [O'Reilly and Bhatti, 1986] might also help bacteria to
reach the internalized epitopes by stripping off surface structures.
8.3. Implications of the findings
It is evident from the difference in the incidence of bacterial meningitis and the
carriage rate of the bacteria responsible for meningitis that nasopharyngeal
colonization is not sufficient for the disease. There must be qualitative or quantitative
changes in the nature of the host-parasite interactions that lead to invasive disease.
Binding of pathogens in overwhelming numbers might override the host clearance
mechanisms. Invasion might result from establishment of a closer relationship
through a different binding mechanism. The enhanced binding of bacteria to
RSV-infected cells through ligands other than pili indicate that infection with RSV
might be one of the factors contributing to increased colonization of bacteria leading
to invasive bacterial disease.
Identification of components on virus-infected cells involved in bacterial binding
might be helpful in the search for bacterial epitopes that are involved in colonization
and that might induce immunity. Isolation and characterization of the human immune
response to the adhesins or the bacteria that bind to glycoprotein might provide a new
approach to vaccination against meningococci.
Binding of RSV particles and G glycoprotein in secretions to bacteria in individuals
with RSV-infection might provide bacteria with a new adhesin to bind to mucosal
cells. Circulatory complement fixing antibodies to the virus might, in contrast,
contribute to bacterial killing mechanisms. RSV-infection might predispose to
bacterial meningitis in young children during primary virus infection only. The
search for an appropriate vaccine against RSV-infection could therefore be relevant to
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the prevention of bacterial meningitis.
8.4. Further studies
Flow cytometry is a reproducible, rapid and objective method and can be
conveniently used for analysis of binding of FITC-labelled bacteria in future studies.
The method, however, could be modified by using labels of two different colours.
Analysis of binding of FTTC-labelled (green) bacteria to cells in cultures with a mixed
population of uninfected and virus-infected cells could be simplified by using a red
fluorescent dye conjugated to antibodies to viral structures. A hypothetical histogram
from this analysis is illustrated in Figure 8.1. With this technique many variations in
the experimental methods (Chapter 5) such as errors in counting cells in different
samples and phasic variations in the samples can be avoided.
The other difficulty in these binding studies with flow cytometry is the inability to
express the mean fluorescence obtained from FITC-labelled bacteria bound to cells as
an actual number of bacteria per cell since the fluorescence emitted by one bacterium
is not known. The flow cytometer is equipped with a sorter system in which cells
from a specified window drawn on a histogram can be isolated. Cells could be sorted
for each level of mean fluorescence and examined by light microscopy for average
number of bacteria per cell. This relationship might be applied to determination of
the numbers of bacteria bound per cell.
There are antigenic and structural variations in the G glycoprotein of different strains
of RSV while only few variations are reported for the F and other viral proteins
[Walsh and Hruska, 1983; Ward et al., 1984; Johnson et al., 1987; Walsh et al.,
1987]. G glycoprotein of 18573 strain (a subgroup B strain) has a lower molecular
weight of 78K compared with 84K of the Long strain (a subgroup A strain, as is the
Edinburgh strain used in the present studies) [Walsh et al., 1987]. The amino acid
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Green fluorescence
Figure 8.1. A hypothetical histogram from a flow cytometric
analysis of a mixed population of uninfected and
virus-infected cells incubated with red fluorescein-labelled
anti-virus antibodies and green fluorescein-labelled
bacteria.
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homology between these two strains is 53% [Johnson et al., 1987]. Despite these
differences, the secondary and tertiary structure of G glycoprotein of different groups
are similar. Cysteine residues (n=4) in the polypeptide occupy conserved sites in the
region of residues 173 to 186 that determine the shape of the glycoprotein. The
hydrophobic region proposed to be the epitope that attaches to cells is also conserved
in different RSV strains [Satake et al., 1985; Johnson et al., 1987]. Evidence that this
conserved hydrophobic epitope is the attachment site for bacteria could be obtained
from similar studies with HEp-2 cells infected with other strains of RSV.
Cell lines deficient in the expression of enzymes responsible for glycosylation and
mutants transfected with human gene(s) responsible for the enzymes might be an
appropriate model to investigate the biochemical structures involved in bacterial
adhesion.
HEp-2 cells can be employed to demonstrate the effect of RSV-infection on binding
of other bacteria, e.g., Strep, pneumoniae responsible for meningitis. Cell culture
models can be used to study the effect of infection with other respiratory tract viruses,
e.g., rhinovirus, adenovirus and parainfluenza virus, on binding of bacteria.
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All the particles (cells or bacteria) detected in the flow cytometer were recorded in a
histogram with two parameters, log forward angle (X-axis) and log 90° light scatter
(Y-axis). Further analysis for fluorescence was carried out on the main populations of
particles selected by bitmaps which excluded debris and clumps. Both the HEp-2
cells and bacteria were detected in one histogram to show the relative positions of the
two populations (Fig 10.1). The cells were recorded outside the bitmap used to
surround bacteria 10.2.a. The subpopulation of events within this bitmap consisted of
85% (n=10,308) of total particles detected in the sample containing bacteria. Since
cell population was not completely visualized on the histogram, the forward angle
light scatter-filter was used to reduce the signals for size. The bitmap used for cells is
illustrated in Fig 10.2.b. The fraction of cell population recorded within the boundries
of the bitmap consisted of 89% (n=2538) of total particles detected. The position of
the bitmap (for cells or bacteria) for all the samples in any one experiment was
constant.
Fig 10.1. Positions of the records obtained from bacteria (A) and cells (B).
Fig 10.2. Position of the bitmap drawn around the main population of bacteria (a) and
HEp-2 cells (b).
10.1.2. Control and test histograms
Drawings in Fig 2 represent typical histograms obtained with HEp-2 cells, uninfected
cells or RSV-infected cells incubated with FITC-labelled bacteria.
Log green fluorescence
Fig 10.3. Typical histograms showing fluorescence recorded on (a) HEp-2 cells,
(b) uninfected HEp-2 cells incubated with FITC-labelled bacteria (250 bacteria :
cell) and (c) RSV-infected HEp-2 cells incubated with the bacteria at the same
ratio.
10.1.3. Gain
The signals of light scatter and fluorescence from particles are gathered by
appropriately placed sensors. Four channels, forward angle light scatter, 90 degree
light scatter and two fluorescence channels, are set up to carry the signals. Each
channel is split into two paths, one with a logarithmic scale and the other with a linear
scale. The linear scale can be amplified arithmetically by factors (gain) 1, 2, 5,10, 20,
50 and 100 (Fig 2b).
The amplifications are used to keep the record of events within the limits of the mean
channel-histogram with an appropriate spread. For instance, the binding of FITC-
labelled bacteria to uninfected cells at a given ratio might be recorded on the linear
scale at gain 5. If bacteria at the same ratio bind to RSV-infected cells in higher
numbers, the record of fluorescence of this sample at gain 5 might be out of upper
limits of the histogram. Use of a lower gain, 1 or 2, is more appropriate to contain the
record within the histogram. [Reference Manual (a)].
Green fluorescence Green fluorescence
Fig 10.4. Typical example of the mean values of fluorescence
of a given fluorescent subpopulation of cells obtained at
different gains.
10.1.4. Immunoanalysis programme
Data obtained from the samples can be analysed for the proportion of positive and
negative subpopulations by this programme. In the example given in Fig 3 the use of
the cursor to determine the percentage of positive cells in the test population results in
an underestimation. It is apparent that all the cells in the test sample have moved to
the right on the X-axis with relation to the control sample. The immunoanalysis
programme uses the information obtained from the negative control histogram to
draw a hypothetical histogram representing positive subpopulation from the test
sample.
The conditions required for this analysis were satisfied by the data presented in this
study: 1) a match region between control and test histograms was established; 2) the
histograms with identical channel numbers were subjected to the analysis. [Reference
manual (b)].
Fig 10.5. Histograms with log green fluorescence from (a) control
sample and (b) test sample merged together
10.2. Calculation of binding index
A binding index for each sample in the study was calculated by multiplying the
percentage of positive cells and the mean fluorescence of positive subpopulation. In
similar studies in which binding of yeasts to epithelial cells was examined., a greater
variation was found in percentage values compared with mean values in different
experiments [Aly, 1992], It has been suggested that mean numbers of bacteria
attached to whole population of cells provide a more accurate estimate of
adhesiveness [Freter and Jones, 1983], In the present study the data were presented as
binding indices (Bis) since the virus infection might affect the percentage of cells
binding bacteria and the mean numbers of bacteria bound. Table 1. illustrates




% Mean BI % Mean BI
NYC 81 21 1701 79 23 1817
GC 80 23 1840 95 21 1995
BBA 92 73 6716 99 84 8316
Table 10.1. An example of calculation of binding indices from an
experiment with FITC-labelled C:2b:P1.2 grown on different culture media
bound to uninfected or RSV-infected HEp-2 cells at a ratio of 640 bacteria
per cell.
10.3. Daily variations in the experiments
There were wide variations in the figures obtained from the Bis in different binding
experiments. The factors considered to contribute to these variations and their
possible effects on the results are discussed in section 5.4.2. In Table 2 Bis from 6
individual experiments with FITC-lablled bacteria,HEp-2 cells and cells infected with
RSV at M.O.I. 1.0 are given. Binding was higher in some experiments compared with














1 180 241 274 291 586 737
2 162 100 167 292 219 618
3 181 163 170 308 - -
4 51 76 258 1060 845 1655
5 486 613 1617 2371 2260 4396
6 61 86 97 130 168 368
Table 10.2. Binding indices for six experiments with FITC-labelled
C:2b:P1.2 and HEp-2 cells or HEp-2 cells infected with RSV at M.O.I.
1.0 (24 hr post-infection).
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radiographs are commonly inadequate for diagnosing
conditions such as spondylitis, metastasis at the base of
a pedicle, and listhesis,18 and therefore, apparently
normal routine radiographs should not be considered
adequate if the clinical picture indicates important
disease.
It is surprising that so few patients were fully
examined and that so many were not examined before
the radiographs were requested. Although patients
may forget much ofwhat their general practitioner tells
them in a consultation, we consider that most will
remember whether or not they have been examined. At
this unit most patients will have had their examination
performed within a few days of the request so that
elapsed time does not become a major factor in
accuracy of recall. We thus believe that our figures are a
reasonable approximation to the truth. It can only be
that most of the doctors in our sample currently make
their decision to request radiographs based on the
patient's history and that the examination findings are
unlikely to alter this decision one way or the other. We
hope that dissemination of the college guidelines will
help to modify this decision making process.
Few of the general practitioners we contacted were
aware of the college guidelines, and most expressed an
interest in seeing them. Radiologists should strive to
ensure that their local general practitioners are in¬
formed of the guidelines and should discuss their
implications with them.
Despite the pessimism of some authors," there is
evidence that educating clinicians about radiology can
reduce the number of unnecessary examinations,2021
and in view of the many patients referred to our
department for lumbar spine radiography, we hope
that widespread acceptance of the guidelines will result
in optimal use of radiological services. We also believe
that there is a need for a guided increase in public
awareness regarding the radiation engendered in
diagnostic radiology. Though we do not wish to cause
unnecessary concern, the community as a whole would
benefit from a reduction in medical radiation that
might follow reduced demand from patients to have
radiographic examinations for painful but benign
conditions.
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Objective—To determine whether non-secretion
of blood group antigens is associated with respira¬
tory virus diseases.
Design—Study of secretor status in patients with
respiratory virus diseases determined by an enzyme
linked immunosorbent assay (ELISA) developed to
identify Lewis (Le) blood group antigen phenotypes
(Lea non-secretor; Leb secretor).
Subjects—Patients aged 1 month to 90 years in
hospital with respiratory virus diseases (584 nasal
specimens).
Main outcome measures—Criteria for validation
of ELISA (congruence between results on ELISA
testing of 1155 saliva samples from a previous study
and previously established results on haemaggluti-
nation inhibition (HAI) testing, proportions of Lea,
Leb, and Le~ phenotypes in 872 samples of nasal
washings from a previous study compared with the
normal population). Secretor status of patients
determined by ELISA and viruses isolated.
Results—Agreement between HAI and ELISA for
1155 saliva samples was 97%. Lewis antigens were
detected by ELISA in 854 (97-9%) of nasal washings
(Lea 233 (26-7%), Leb 621 (71-2%), and Le~ 18
(2-1%)) in proportions predicted for a northern
European population. Secretors were significantly
overrepresented among patients from whom
influenza viruses A and B (55/64, 86%; p<0 025),
rhinoviruses (63/72, 88%; p<0-01), respiratory
syncytial virus (97/109, 89%; p<0-0005), and echo-
viruses (44/44, p<0 0005) had been isolated com¬
pared with the distribution of secretors in the local
population.
Conclusion—Secretion of blood group antigens is
associated with respiratory virus diseases.
Introduction
Susceptibility to a variety of bacterial and superficial
fungal infections is associated with the genetically
controlled inability of individual subjects to secrete the
water soluble form of the ABO blood group antigens
into body fluids (non-secretion).1"7 Non-secretors are
also significantly overrepresented among patients with
some autoimmune diseases for which infectious
triggers have been proposed.812 Although studies of
associations between ABO blood groups and suscept¬
ibility to natural or experimental viral infections have
been reported,"'15 there are no published studies of
secretor status and viral infection. In this study we
tested the hypothesis that non-secretors might also be
at increased risk of viral illnesses.
Because the quantities of material available from
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patients with viral diseases were too small to determine
secretor status by the usual haemagglutination
inhibition method,16 we developed an enzyme linked
immunosorbent assay (ELISA) to detect Lewis blood
group antigens in the specimens. Non-secretors
express only Lewis3 (Le3) antigen and secretors express
Lewisb (Leb) antigen on their red blood cells and in
their body fluids.
Materials and methods
elisa for lewis antigens
To detect the presence of Le3 and Leb blood group
antigens in body fluids by ELISA wells of polystyrene
microtitre plates (Dynatech, Billingshurst, Sussex)
were coated overnight at 4°C with 100 pi of mono¬
clonal Le3 antibody (LM 112/161) or 100 pi Leb
antibody (LM 129/81 anti-LebL) (provided by R H
Fraser, Glasgow and West Scotland Blood Transfusion
Service). Le3 antibody was diluted 1 in 25 and Leb
diluted 1 in 20 in 50 mM sodium carbonate buffer
(pH 9-6). All further procedures were carried out at
room temperature except when stated otherwise. The
wells were washed three times with 0T M phosphate
buffered saline containing 01% (wt/vol) bovine serum
albumin and 0 05% (vol/vol) Tween 20 (washing
buffer). The wells were blocked with 150 pi of
phosphate buffered saline with 1% (wt/vol) bovine
serum albumin (blocking buffer) for 15 minutes. The
buffer was removed and the wells washed twice with
washing buffer.
Dilutions of saliva from known secretors or non-
secretors were used in each plate as controls. Test wells
contained 100 pi of the specimen (saliva, nasal wash¬
ings, or respiratory secretions) which had been boiled
for 30 minutes to inactivate enzymes, bacteria, or
viruses. Samples of saliva were diluted 1 in 20 in
blocking buffer for detecting Leb antigen and 1 in 100
for detecting Lea antigen. The more dilute nasal
washings or respiratory specimens were diluted 1 in 10
in blocking buffer to detect Le3 antigen but were used
undiluted to detect Leb antigen.
After incubation for one hour the wells were washed
three times and 100 pi of polyclonal goat anti-Le3
antibody (Behring, Marburg, West Germany) diluted
1 in 500 in blocking buffer or 100 pi of polyclonal goat
anti-Leb antibody (Behring) diluted 1 in 250 in block¬
ing buffer were added to the wells of the appropriate
plates. After 30 minutes' incubation the plates were
washed three dmes, and 100 pi of horseradish
peroxidase conjugated donkey antigoat immuno¬
globulin (Scottish Antibody Production Unit,
Carluke, Lanarkshire) diluted 1 in 250 in blocking
buffer was added. After overnight incubation at 4°C
the plates were washed three times and 100 pi of
orthophenylene diamine (40 mg in 100 ml 01 M
phosphate citrate buffer, pH 5) activated with 40 pi
hydrogen peroxide (30%) were added to each well. The
colour was allowed to develop for 10-15 minutes, and
the reaction was stopped by adding 50 pi of 12-5%
sulphuric acid to each well.
Absorbance at 490 nm was measured with a plate
reader (Dynatech). Samples were tested in duplicate,
and the readings were averaged. The average reading
for each sample was compared with the results
obtained for dilutions of saliva from secretors (diluted
1 in 20) and non-secretors (diluted 1 in 100) in the same
plate. Values equal to or above that of the control were
considered to be positive. The subjects from whom the
samples were obtained were classified as non-secretors
if only Le3 antigen was detected or as secretors if Leb
antigen or Le3 and Leb antigens were detected.
samples and controls
To assess the method we compared the results
obtained by the ELISA with those obtained by a
haemagglutination inhibition assay16 for 1155 saliva
specimens collected during the Stonehouse survey."
Nasal secretions were collected from 26 members of
staff whose secretor status and Lewis blood group
antigens had been previously determined. The secre¬
tions were collected with cotton wool swabs, inocu¬
lated into virus transport medium, and the transport
medium processed and assayedTor presence of Lewis
antigens. Nasal washings (n=872) obtained as part of
other studies at the Medical Research Council's
Common Cold Unit were also tested to determine if
Lewis antigens could be detected in diluted nasal
secretions. They had originally been obtained from
volunteers for assessment of secretory antibodies and
had been stored at -20°C for four to five years.
As there is no association between sex and secretor
status or sex and the Lewis blood group" the distribu¬
tion of Le3 and Leb antigens in the local population was
determined with red blood cells from 363 women
attending antenatal clinics at the Royal Infirmary,
Edinburgh, by the standard tube agglutination method
with the monoclonal Le3 and Leb antibodies referred to
above in 10% dextran and 2% bovine serum albumin.
The results were compared with those of a previous
study of the local population in which secretor status of
334 blood donors was determined from saliva by
haemagglutination inhibition.3 Specimens sent to the
regional virus laboratory for examination (n=584),
mainly from patients aged from 1 month to 90 years in
hospital with symptoms of viral disease, were used in
this study. These were aspirated respiratory secretions
or nasal or throat swabs inoculated into virus transport
medium which had been stored at -70°C after culture
for virus (table I). The results for the local population
and test specimens were compared by the x2 test
incorporating Yates's correction factor. Odds ratios
and 95% confidence intervals were calculated by the
exact method.




Local antenatal clinic Blood 363
Local antenatal clinic' Saliva 334
Stonehouse survey17 Blood and saliva 1155
MRC Common Cold Unit Nasal washings 872





Regional virus laboratory Nasal secretions
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assessment of elisa for detecting lewis antigens
in body fluids
Le3 or Leb antigens or both, were detected by
ELISA in 1089 of the 1155 (94-3%) specimens of saliva
for which secretor status had been determined by
haemagglutination inhibition. The results of ELISA
for Lewis antigens and of the haemagglutination inhi¬
bition assay agreed for 1058 of the 1089 Lewis positive
specimens (97%), 796 Leb antigen positive (secretors)
and 262 Le3 antigen positive (non-secretors). The
results for the two assays disagreed for 31 specimens,
27 Le3 antigen positive (but secretors by haemag¬
glutination inhibition) and four Leb antigen positive
(but non-secretors by haemagglutination inhibition).
In 66 specimens (5-7%) Lewis antigens were not
detected by ELISA: 30 were from secretors and 36
from non-secretors. Lewis phenotype determined by
agglutination of red blood cells for 124 of these donors
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agreed with the results of the ELISA for 119 (96%) of
those tested. The ELISA correctly identified the Lewis
antigen present in nasal secretions of all 26 laboratory
staff. Among the 872 nasal washings obtained from the
Common Cold Unit, Lewis antigens were detected in
854 (97-9%); Lea antigen in 233 (26-7%); Leb antigen
in 621 (71-2%); and no Lewis antigen in 18 (2-1%).
This finding does not differ from the distribution of
those phenotypes in most northern European popula¬
tions."
LEWIS PHENOTYPES OF LOCAL POPULATION
Among 363 blood specimens from the antenatal
clinic in which the Lewis antigens were detected, 28%
were Lea antigen positive only and 72% were Leb
antigen positive (tabe II). These results were not
significantly different from the proportions of non-
secretors (26-6%) and secretors (73 4%) determined in
a previous study by haemagglutination inhibition tests
of 334 samples of saliva from local blood donors.3
LEWIS PHENOTYPE OF PATIENTS WITH VIRAL
ILLNESSES
In 192 of the 584 (33%) patients' specimens
examined by ELISA not enough Lewis antigen was
detected for definite classification: 81 showed border¬
line readings, and in 111 no antigen was detectable.
The results obtained with these specimens most prob¬
ably reflect degradationofthe antigens due to delays in
their transportation to the laboratory. No virus was
isolated from 38 (20%) of these 192 specimens. Among
the 392 specimens in which either or both Lewis
antigens were definitely detected, no virus was isolated
from 36 (9%) (x2=12-17, p<0-0()05). The proportion
of unclassifiable specimens did not vary significantly
with respect to isolation of any particular virus. As the
specimens giving negative and borderline results for
Lewis antigens could not be classified as being from
secretors or non-secretors they were eliminated from
further analysis.
TABLE II—Lewis phenotype and secrelor status ofpatients and controls and results ofvirus culture
Le'+b~ Le'-b+/Le-+b+
(non-secretors) (secretors)
Source of Odds ratio* (95%







































2-42 (1-13 to 5-77)
2-49(1 -06 to 6-76)
2-18 (0-46 to 20-53)
1-17(0-63 to 2-26)
<0 0005 3-20(1 66 to 6-67)
<0-01 2-77 (1-31 to 6-57)
44(100) 15-25 <0-0005 ac(4-41tooc)
27(75) 0 06 >0-05 1 19(0-52 to 2-97)
*Odds ratio compared with local controls.
Table II compares the isolation of viruses from non-
secretors and secretors. Compared with the local
population, there was a significantly higher proportion
of secretors among subjects from whom the following
viruses were isolated: influenza A virus (p<0 05),
rhinovirus (p<001), respiratory syncytial virus
(p<0 0005), and echoviruses (p<0 0005). Although
11 of 13 specimens containing influenza B virus were
from secretors, the numbers were too small to be
significant. This pattern was not observed for the 67
specimens from which parainfluenza virus was isolated
or the 36 from which no vims was isolated. In these two
groups of specimens the proportions that were Leb
antigen positive (secretors) and Lea antigen positive
(non-secretors) were similar to those of the local
population.
Discussion
Determination of Lewis phenotype is a good control
for haemagglutination inhibition assays for ABO
antigens which have been the standard method for
determining secretor status. Agreement between the
Lewis phenotypes and results of the haemagglutina¬
tion inhibition assay for 1089 saliva specimens was
97%. "False secretors," of Lea phenotype but secretors
by haemagglutination inhibition, were the predomi¬
nant mismatched pairs (27/31, 87%). Results of a
previous study indicate that these are most likely the
result of contamination of saliva by blood owing to
poor oral hygiene or periodontal disease among these
subjects.17 Dilution of small samples to provide enough
material for the haemagglutination inhibition test is
probably the source of the small proportion (0 004%)
of "false non-secretors," who are of Leb phenotype but
non-secretors by haemagglutination inhibition. The
ELISA method eliminates the problem of contamina¬
tion of non-secretor saliva by red blood cells and it can
be carried out on smaller volumes than those needed
for haemagglutination inhibition. The method also
detected Lewis antigens in 854 (98%) of the 872
specimens from the Common Cold Unit, indicating
that the method can be used to detect these antigens in
diluted nasal secretions.
The nasal washings from volunteers at the Common
Cold Unit were originally collected for determining
secretory antibody titres and were frozen soon after
collection, which would preserve the Lewis antigens;
analysis of the results found the expected proportion
(2%) of specimens negative for Lewis antigen. The
high proportion of specimens from patients in hospital
with viral illness for which borderline readings were
obtained or in which no Lewis antigen was detected
might be due, in part, to collection techniques and time
taken for transportation and processing the specimens.
Blood group antigens cannot be reliably detected in
saliva kept overnight at room temperature. There was
a significantly higher proportion of unclassifiable
specimens from which no virus was isolated (20%)
compared with the proportion of specimens in which
Lewis antigens were definitely detected but from
which no virus was isolated (9%) (p<0 0005). The
proportion of unclassifiable specimens was not greater
among the very young age groups (<24 months), from
whom nasopharyngeal secretions are usually obtained.
Although the Lewis antigens were correctly identified
in all the samples of transport medium inoculated with
nasal swabs obtained from 26 laboratory staff, secre¬
tions provide a larger quantity of material for isolating
virus and detecting Lewis antigen.
Previous studies found non-secretion to be associ¬
ated with various bacterial diseases and superficial
yeast infections and with carriage of some pathogenic
bacteria or yeasts. ""2I These findings contrast with
our present finding in which secretors were over-
represented among those patients with significant
symptoms of respiratory illness and from whom
influenza A virus, rhinovirus, or respiratory syncytial
virus were isolated. Secretors were also significantly
overrepresented among those from whom echoviruses
were isolated; these patients, however, had various
illnesses including meningitis, fever, and vomiting. An
increase in the proportion of secretors was not associ¬
ated with isolation of parainfluenza virus or with the
group of individual subjects from whom no virus was
isolated.
This is the first report of associations between
secretion of blood group antigens and infectious
diseases. There is evidence that the Lea antigen present
in greater amounts on epithelial surfaces of non-
secretors might be one of the receptors for Candida
species,22 and studies in progress indicate that this
might be true for Neisseria meningitidis. The hypothesis
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that antigens present only in secretors (Le°) or in
higher quantities in secretors (H type 1 in addition to H
type 2)" might act as one of the receptors for some
viruses is under investigation.
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Objective—To audit the subsequent obstetric
management of women who had had one previous
baby delivered by caesarean section.
Design—Retrospective analysis of a regional
obstetric database.
Setting—Data derived from the 17 obstetric units
in North West Thames region.
Subjects—1059 women who delivered a singleton
fetus of at least 37 weeks' gestation with a cephalic
presentation in 1988 who had a history of one
previous caesarean section and no other deliveries.
Main outcome measures—Mode of delivery, post¬
natal morbidity, and duration of hospital stay.
Results—395 (37%) women were delivered by
elective repeat caesarean section and 664 (63%) were
allowed a trial of labour. Maternal height and birth
weight of the previous infant differed significantly
between those who were and those who were not
allowed to labour. 471 (71%) of those allowed to
labour achieved a vaginal delivery. In individual
units there was no significant correlation between
the proportion of patients allowed to labour and the
rate of the successful trial of labour. There was a
trend towards greater success rates in units that
allowed a longer duration of labour (p<0 05) and
units with greater use of oxytocin for augmentation
of labour (not significant). Both elective and intra¬
partum caesarean section was associated with a
significantly higher rate of postnatal infection than
vaginal delivery (14-7% and 16-0% v 3-4%).
Conclusions— In patients with a history of
caesarean section there is no evidence that the
likelihood of successful vaginal delivery after trial of
labour is modified by the proportion of such patients
allowed the option of attempted vaginal delivery.
Until selection criteria of adequate prognostic value
can be identified a more liberal approach to allowing
women a trial of labour seems justified.
Introduction
The rising incidence of caesarean birth in Britain
and elsewhere is a cause for concern both in terms of
the associated increase in clinical and social morbidity
for the mother and increased cost to the health service.
Repeat caesarean section makes a major contribution
to the overall rate of caesarean section. One strategy for
reducing the rate of caesarean birth, therefore, is to
allow women with a history of lower segment caesarean
section the option of a trial of labour in their next
pregnancy unless there are specific contraindications.
Many studies attest to the safety of a properly
conducted trial of labour in women who have pre¬
viously delivered by caesarean section, and successful
vaginal delivery can be expected in around two thirds
of such cases. In a comprehensive review Lavin et al
concluded that a properly managed trial was associated
with an acceptably low incidence of scar dehiscence
and perinatal mortality.1 Furthermore, no maternal
deaths were identified. This is in contrast to the
recognised contribution of repeat elective caesarean
section to maternal mortality.2
Factors known to influence the outcome of a trial of
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